Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	cell morphogenesis	HSPG2 NRCAM MYCBP2 DVL1 LAMA3 DAG1 CDH23 SHROOM2 ADAM8 SHANK3 CCDC88C DST LLGL1 NBEAL2 PKHD1 LRP1 RERE ULK2 MOV10 RBFOX2	6.89e-07	1194	98	20	GO:0000902
GeneOntologyBiologicalProcess	animal organ morphogenesis	HSPG2 TBX3 DVL1 GATA4 LAMA3 DAG1 CDH23 SIX4 DLL1 SHROOM2 SHANK3 ESRP2 HEYL ACAN PKHD1 PAX1 TAB1 USH2A CDON	7.06e-06	1269	98	19	GO:0009887
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	HSPG2 NRCAM MYCBP2 DVL1 LAMA3 DAG1 CDH23 SHANK3 DST LLGL1 LRP1 RERE ULK2 RBFOX2	1.17e-05	748	98	14	GO:0048667
GeneOntologyBiologicalProcess	central nervous system development	HSPG2 TBX3 NRCAM MYCBP2 SCYL3 DAG1 DLL1 SHROOM2 SHANK3 CIC HOXC10 LLGL1 ATXN1 ACAN LRP1 RERE RBFOX2 CDON	1.21e-05	1197	98	18	GO:0007417
GeneOntologyBiologicalProcess	anterior/posterior pattern specification	TBX3 GATA4 DLL1 HEYL HOXC10 DMRT2 PAX1 CDON	2.35e-05	247	98	8	GO:0009952
GeneOntologyBiologicalProcess	neuron projection morphogenesis	HSPG2 NRCAM MYCBP2 DVL1 LAMA3 DAG1 SHANK3 DST LLGL1 LRP1 RERE ULK2 MOV10 RBFOX2	2.54e-05	802	98	14	GO:0048812
GeneOntologyBiologicalProcess	neuron projection development	HSPG2 NRCAM MYCBP2 DVL1 LAMA3 ARFGEF1 DAG1 CDH23 DGKG RAPGEF1 SHANK3 DST LLGL1 LRP1 RERE ULK2 MOV10 RBFOX2	3.12e-05	1285	98	18	GO:0031175
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	HSPG2 NRCAM MYCBP2 DVL1 LAMA3 DAG1 SHANK3 DST LLGL1 LRP1 RERE ULK2 MOV10 RBFOX2	3.20e-05	819	98	14	GO:0120039
GeneOntologyBiologicalProcess	regulation of neurogenesis	DAG1 DLL1 SHANK3 HEYL PER2 ATXN1 ACAN LRP1 ULK2 CDON SORL1	3.34e-05	515	98	11	GO:0050767
GeneOntologyBiologicalProcess	cell projection morphogenesis	HSPG2 NRCAM MYCBP2 DVL1 LAMA3 DAG1 SHANK3 DST LLGL1 LRP1 RERE ULK2 MOV10 RBFOX2	3.51e-05	826	98	14	GO:0048858
GeneOntologyBiologicalProcess	neuron development	HSPG2 NRCAM MYCBP2 SCYL3 DVL1 LAMA3 ARFGEF1 DAG1 CDH23 DGKG RAPGEF1 SHANK3 DST LLGL1 LRP1 RERE ULK2 MOV10 RBFOX2	5.11e-05	1463	98	19	GO:0048666
GeneOntologyBiologicalProcess	axon guidance	HSPG2 NRCAM MYCBP2 DVL1 LAMA3 DAG1 LRP1 ULK2	6.47e-05	285	98	8	GO:0007411
GeneOntologyBiologicalProcess	neuron projection guidance	HSPG2 NRCAM MYCBP2 DVL1 LAMA3 DAG1 LRP1 ULK2	6.63e-05	286	98	8	GO:0097485
GeneOntologyBiologicalProcess	tube development	HSPG2 TCF4 TBX3 DVL1 GATA4 DAG1 SIX4 DLL1 ADAM8 SHANK3 CIC ESRP2 HEYL ATXN1 PKHD1 LRP1 TAB1 GAB1	9.63e-05	1402	98	18	GO:0035295
GeneOntologyBiologicalProcess	myotome development	SIX4 DMRT2	1.33e-04	4	98	2	GO:0061055
GeneOntologyBiologicalProcess	epithelial tube morphogenesis	TBX3 DVL1 GATA4 DAG1 SIX4 DLL1 SHANK3 ESRP2 PKHD1	1.79e-04	421	98	9	GO:0060562
GeneOntologyBiologicalProcess	regulation of nervous system development	DAG1 DLL1 SHANK3 HEYL PER2 ATXN1 ACAN LRP1 ULK2 CDON SORL1	1.86e-04	625	98	11	GO:0051960
GeneOntologyBiologicalProcess	cell junction organization	NRCAM MYCBP2 DVL1 LAMA3 DAG1 RAPGEF1 SIX4 SHROOM2 SHANK3 DLGAP3 DST PKHD1 LRP1 IGSF9B	2.02e-04	974	98	14	GO:0034330
GeneOntologyBiologicalProcess	heart development	HSPG2 TBX3 DVL1 GATA4 DAG1 DLL1 HEYL LDB3 ACAN LRP1 TAB1 GAB1	2.47e-04	757	98	12	GO:0007507
GeneOntologyBiologicalProcess	hemidesmosome assembly	LAMA3 DST	3.31e-04	6	98	2	GO:0031581
GeneOntologyBiologicalProcess	axonogenesis	HSPG2 NRCAM MYCBP2 DVL1 LAMA3 DAG1 DST LLGL1 LRP1 ULK2	3.60e-04	566	98	10	GO:0007409
GeneOntologyBiologicalProcess	actin filament-based process	SYNPO2 ARHGEF5 GATA4 ARFGEF1 SIX4 SHROOM2 SHANK3 ZYX CCDC88C LDB3 LLGL1 NUP155 LRP1	3.75e-04	912	98	13	GO:0030029
GeneOntologyBiologicalProcess	inner ear morphogenesis	TBX3 DVL1 CDH23 SIX4 DLL1	3.78e-04	129	98	5	GO:0042472
GeneOntologyBiologicalProcess	embryo development	HSPG2 TBX3 DVL1 GATA4 LAMA3 DAG1 CDH23 SIX4 DLL1 SHANK3 HOXC10 DMRT2 SEC24C PAX1 TAB1 GAB1 CDON	4.05e-04	1437	98	17	GO:0009790
GeneOntologyBiologicalProcess	heart looping	TBX3 DVL1 GATA4 DLL1	4.06e-04	73	98	4	GO:0001947
GeneOntologyBiologicalProcess	ear development	TBX3 DVL1 CDH23 SIX4 DLL1 SHROOM2 USH2A	4.23e-04	285	98	7	GO:0043583
GeneOntologyBiologicalProcess	social behavior	DVL1 SHANK3 CIC ATXN1	4.27e-04	74	98	4	GO:0035176
GeneOntologyBiologicalProcess	cardiac septum development	TBX3 GATA4 HEYL LRP1 TAB1	4.50e-04	134	98	5	GO:0003279
GeneOntologyBiologicalProcess	regionalization	TBX3 DVL1 GATA4 DLL1 HEYL HOXC10 DMRT2 PAX1 CDON	4.54e-04	478	98	9	GO:0003002
GeneOntologyBiologicalProcess	radial glia guided migration of Purkinje cell	RERE RBFOX2	4.62e-04	7	98	2	GO:0021942
GeneOntologyBiologicalProcess	regulation of synaptic assembly at neuromuscular junction	MYCBP2 SIX4	4.62e-04	7	98	2	GO:0008582
GeneOntologyBiologicalProcess	regulation of somitogenesis	DLL1 DMRT2	4.62e-04	7	98	2	GO:0014807
GeneOntologyBiologicalProcess	biological process involved in intraspecies interaction between organisms	DVL1 SHANK3 CIC ATXN1	4.73e-04	76	98	4	GO:0051703
GeneOntologyBiologicalProcess	determination of heart left/right asymmetry	TBX3 DVL1 GATA4 DLL1	5.48e-04	79	98	4	GO:0061371
GeneOntologyBiologicalProcess	alternative mRNA splicing, via spliceosome	ESRP2 MBNL2 RBM47 RBFOX2	5.48e-04	79	98	4	GO:0000380
GeneOntologyBiologicalProcess	embryonic morphogenesis	HSPG2 TBX3 DVL1 GATA4 DAG1 CDH23 SIX4 DLL1 SHANK3 HOXC10 CDON	5.69e-04	713	98	11	GO:0048598
GeneOntologyBiologicalProcess	embryonic heart tube morphogenesis	TBX3 DVL1 GATA4 DLL1	5.75e-04	80	98	4	GO:0003143
GeneOntologyBiologicalProcess	anatomical structure formation involved in morphogenesis	HSPG2 TCF4 TBX3 DVL1 GATA4 DAG1 SIX4 DLL1 ADAM8 SHANK3 HEYL LDB3 DMRT2 NBEAL2 PAX1 GAB1 CDON	5.81e-04	1483	98	17	GO:0048646
GeneOntologyBiologicalProcess	regulation of anatomical structure morphogenesis	HSPG2 TCF4 DVL1 GATA4 DAG1 SIX4 DLL1 SHANK3 DMRT2 PKHD1 LRP1 ULK2 GAB1 MOV10	6.26e-04	1090	98	14	GO:0022603
GeneOntologyBiologicalProcess	respiratory system development	GATA4 DAG1 SIX4 CIC ESRP2 ATXN1 TAB1	6.33e-04	305	98	7	GO:0060541
GeneOntologyBiologicalProcess	regulation of cell development	DAG1 DLL1 ADAM8 LILRB1 SHANK3 HEYL PER2 ATXN1 ACAN LRP1 ULK2 RBFOX2 CDON SORL1	6.55e-04	1095	98	14	GO:0060284
GeneOntologyBiologicalProcess	collateral sprouting	DVL1 LRP1 ULK2	7.19e-04	37	98	3	GO:0048668
GeneOntologyBiologicalProcess	neuromuscular process	MYCBP2 DVL1 CDH23 SHANK3 HOXC10 RBFOX2	7.20e-04	225	98	6	GO:0050905
GeneOntologyBiologicalProcess	brain development	HSPG2 TBX3 NRCAM DLL1 SHROOM2 SHANK3 CIC LLGL1 ATXN1 RERE RBFOX2 CDON	7.63e-04	859	98	12	GO:0007420
GeneOntologyBiologicalProcess	L-alpha-amino acid transmembrane transport	SLC36A4 TTYH2 SLC7A6 PER2	7.89e-04	87	98	4	GO:1902475
GeneOntologyBiologicalProcess	negative regulation of cellular component organization	HSPG2 CTC1 ARFGEF1 SHROOM2 LILRB1 SHANK3 PHF2 CCDC88C PER2 LRP1 ULK2 SORL1	8.03e-04	864	98	12	GO:0051129
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	NRIP1 TCF4 TBX3 NELFA DVL1 GATA4 SIX4 DLL1 LILRB1 IKZF4 HEYL HOXC10 DMRT2 ATXN1 PAX1 CDON	8.21e-04	1390	98	16	GO:0045944
GeneOntologyBiologicalProcess	ear morphogenesis	TBX3 DVL1 CDH23 SIX4 DLL1	8.45e-04	154	98	5	GO:0042471
GeneOntologyBiologicalProcess	tube morphogenesis	HSPG2 TCF4 TBX3 DVL1 GATA4 DAG1 SIX4 DLL1 ADAM8 SHANK3 ESRP2 PKHD1 LRP1 GAB1	8.52e-04	1125	98	14	GO:0035239
GeneOntologyBiologicalProcess	heart morphogenesis	TBX3 DVL1 GATA4 DAG1 DLL1 HEYL TAB1	8.55e-04	321	98	7	GO:0003007
GeneOntologyBiologicalProcess	tissue morphogenesis	TBX3 DVL1 GATA4 DAG1 SIX4 DLL1 ADAM8 SHANK3 ESRP2 HEYL PKHD1	8.63e-04	750	98	11	GO:0048729
GeneOntologyBiologicalProcess	regulation of developmental growth	SGIP1 NRCAM MYCBP2 GATA4 SIX4 DLL1 LRP1 ULK2	8.95e-04	421	98	8	GO:0048638
GeneOntologyBiologicalProcess	pattern specification process	TBX3 DVL1 GATA4 DLL1 HEYL HOXC10 DMRT2 PAX1 CDON	8.98e-04	526	98	9	GO:0007389
GeneOntologyBiologicalProcess	axon development	HSPG2 NRCAM MYCBP2 DVL1 LAMA3 DAG1 DST LLGL1 LRP1 ULK2	9.52e-04	642	98	10	GO:0061564
GeneOntologyBiologicalProcess	proximal tubule development	DLL1 HEYL	9.81e-04	10	98	2	GO:0072014
GeneOntologyBiologicalProcess	regulation of neuromuscular junction development	MYCBP2 SIX4	9.81e-04	10	98	2	GO:1904396
GeneOntologyBiologicalProcess	skeletal muscle organ development	GATA4 DAG1 SIX4 DLL1 HEYL CDON	1.01e-03	240	98	6	GO:0060538
GeneOntologyBiologicalProcess	somite development	SIX4 DLL1 DMRT2 PAX1	1.05e-03	94	98	4	GO:0061053
GeneOntologyBiologicalProcess	outflow tract morphogenesis	TBX3 DVL1 GATA4 HEYL	1.05e-03	94	98	4	GO:0003151
GeneOntologyBiologicalProcess	left/right pattern formation	TBX3 DVL1 GATA4 DLL1 DMRT2	1.06e-03	162	98	5	GO:0060972
GeneOntologyCellularComponent	basement membrane	HSPG2 LAMA3 DAG1 DST ACAN USH2A	2.51e-05	122	99	6	GO:0005604
GeneOntologyCellularComponent	anchoring junction	HSPG2 SYNPO2 ARHGEF5 ZNF185 LAMA3 DAG1 DLL1 SHROOM2 ZYX CCDC88C LDB3 DST LLGL1 LRP1 GAB1	5.36e-05	976	99	15	GO:0070161
GeneOntologyCellularComponent	adherens junction	LAMA3 DAG1 DLL1 SHROOM2 ZYX LDB3 LLGL1	6.76e-05	212	99	7	GO:0005912
GeneOntologyCellularComponent	cell-cell junction	LAMA3 DAG1 DLL1 SHROOM2 ZYX CCDC88C LDB3 DST LLGL1 GAB1	4.93e-04	591	99	10	GO:0005911
GeneOntologyCellularComponent	histone deacetylase complex	NRIP1 SRCAP KMT2E RERE	7.14e-04	85	99	4	GO:0000118
Domain	TCRP1	FAM168B FAM168A	2.67e-05	2	97	2	PF14944
Domain	FAM168A/MANI	FAM168B FAM168A	2.67e-05	2	97	2	IPR029247
Domain	EGF_LAM_2	HSPG2 LAMA3 USH2A	4.98e-04	30	97	3	PS50027
Domain	EGF_LAM_1	HSPG2 LAMA3 USH2A	4.98e-04	30	97	3	PS01248
Domain	LAMININ_IVA	HSPG2 LAMA3	7.32e-04	8	97	2	PS51115
Domain	Laminin_B	HSPG2 LAMA3	7.32e-04	8	97	2	PF00052
Domain	LamB	HSPG2 LAMA3	7.32e-04	8	97	2	SM00281
Domain	Laminin_IV	HSPG2 LAMA3	7.32e-04	8	97	2	IPR000034
Domain	Laminin_EGF	HSPG2 LAMA3 USH2A	7.88e-04	35	97	3	PF00053
Domain	EGF_Lam	HSPG2 LAMA3 USH2A	7.88e-04	35	97	3	SM00180
Domain	PDZ	SYNPO2 DVL1 SHROOM2 SHANK3 LDB3	8.44e-04	141	97	5	PF00595
Domain	LAM_G_DOMAIN	HSPG2 LAMA3 USH2A	1.00e-03	38	97	3	PS50025
Domain	Laminin_EGF	HSPG2 LAMA3 USH2A	1.00e-03	38	97	3	IPR002049
Domain	PDZ	SYNPO2 DVL1 SHROOM2 SHANK3 LDB3	1.05e-03	148	97	5	SM00228
Domain	-	SYNPO2 DVL1 SHROOM2 SHANK3 LDB3	1.11e-03	150	97	5	2.30.42.10
Domain	PDZ	SYNPO2 DVL1 SHROOM2 SHANK3 LDB3	1.15e-03	151	97	5	PS50106
Domain	LDLR_class-A_CS	HSPG2 LRP1 SORL1	1.17e-03	40	97	3	IPR023415
Domain	Laminin_G_2	HSPG2 LAMA3 USH2A	1.17e-03	40	97	3	PF02210
Domain	PDZ	SYNPO2 DVL1 SHROOM2 SHANK3 LDB3	1.18e-03	152	97	5	IPR001478
Domain	EGF	HSPG2 LAMA3 DLL1 ADAM8 LRP1 SORL1	1.42e-03	235	97	6	SM00181
Domain	BAH	TNRC18 RERE	1.42e-03	11	97	2	SM00439
Domain	BAH	TNRC18 RERE	1.42e-03	11	97	2	PF01426
Domain	BAH	TNRC18 RERE	1.42e-03	11	97	2	PS51038
Domain	BAH_dom	TNRC18 RERE	1.42e-03	11	97	2	IPR001025
Domain	LamG	HSPG2 LAMA3 USH2A	1.54e-03	44	97	3	SM00282
Domain	fn3	NRCAM IGSF9B USH2A CDON SORL1	1.57e-03	162	97	5	PF00041
Domain	Ldl_recept_a	HSPG2 LRP1 SORL1	1.65e-03	45	97	3	PF00057
Domain	ZnF_GATA	GATA4 RERE	1.70e-03	12	97	2	SM00401
Domain	-	HSPG2 LRP1 SORL1	1.75e-03	46	97	3	4.10.400.10
Domain	EGF-like_dom	HSPG2 LAMA3 DLL1 ADAM8 LRP1 SORL1	1.90e-03	249	97	6	IPR000742
Domain	LDLRA_1	HSPG2 LRP1 SORL1	1.98e-03	48	97	3	PS01209
Domain	LDLRA_2	HSPG2 LRP1 SORL1	2.10e-03	49	97	3	PS50068
Domain	LDrepeatLR_classA_rpt	HSPG2 LRP1 SORL1	2.10e-03	49	97	3	IPR002172
Domain	LDLa	HSPG2 LRP1 SORL1	2.10e-03	49	97	3	SM00192
Domain	EGF_1	HSPG2 LAMA3 DLL1 ADAM8 LRP1 USH2A	2.14e-03	255	97	6	PS00022
Domain	-	HSPG2 NRCAM MYCBP2 DAG1 LILRB1 PKHD1 IGSF9B USH2A CDON SORL1	2.32e-03	663	97	10	2.60.40.10
Domain	Ldl_recept_b	LRP1 SORL1	2.33e-03	14	97	2	PF00058
Domain	LDLRB	LRP1 SORL1	2.33e-03	14	97	2	PS51120
Domain	EGF-like_CS	HSPG2 LAMA3 DLL1 ADAM8 LRP1 SORL1	2.41e-03	261	97	6	IPR013032
Domain	EGF_2	HSPG2 LAMA3 DLL1 ADAM8 LRP1 SORL1	2.59e-03	265	97	6	PS01186
Domain	Znf_GATA	GATA4 RERE	2.68e-03	15	97	2	IPR000679
Domain	GATA	GATA4 RERE	2.68e-03	15	97	2	PF00320
Domain	LY	LRP1 SORL1	2.68e-03	15	97	2	SM00135
Domain	LDLR_classB_rpt	LRP1 SORL1	2.68e-03	15	97	2	IPR000033
Domain	FN3	NRCAM IGSF9B USH2A CDON SORL1	2.79e-03	185	97	5	SM00060
Domain	GATA_ZN_FINGER_1	GATA4 RERE	3.06e-03	16	97	2	PS00344
Domain	Laminin_N	LAMA3 USH2A	3.06e-03	16	97	2	IPR008211
Domain	LAMININ_NTER	LAMA3 USH2A	3.06e-03	16	97	2	PS51117
Domain	Laminin_N	LAMA3 USH2A	3.06e-03	16	97	2	PF00055
Domain	GATA_ZN_FINGER_2	GATA4 RERE	3.06e-03	16	97	2	PS50114
Domain	LamNT	LAMA3 USH2A	3.06e-03	16	97	2	SM00136
Domain	Laminin_G	HSPG2 LAMA3 USH2A	3.41e-03	58	97	3	IPR001791
Domain	Ig-like_fold	HSPG2 NRCAM MYCBP2 DAG1 LILRB1 PKHD1 IGSF9B USH2A CDON SORL1	3.64e-03	706	97	10	IPR013783
Domain	FN3	NRCAM IGSF9B USH2A CDON SORL1	3.81e-03	199	97	5	PS50853
Domain	-	PLPPR3 PLPPR2	3.87e-03	18	97	2	1.20.144.10
Domain	acidPPc	PLPPR3 PLPPR2	3.87e-03	18	97	2	SM00014
Domain	FN3_dom	NRCAM IGSF9B USH2A CDON SORL1	4.69e-03	209	97	5	IPR003961
Domain	P_Acid_Pase_2/haloperoxidase	PLPPR3 PLPPR2	4.77e-03	20	97	2	IPR000326
Domain	PAP2	PLPPR3 PLPPR2	4.77e-03	20	97	2	PF01569
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HSPG2 MYCBP2 CTC1 DVL1 RAPGEF1 SRCAP DLL1 FBXO46 CIC ESRP2 CCDC88C HEYL TNRC18 DST PER2 NBEAL2 SLC45A1 ULK2	2.49e-09	1105	100	18	35748872
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SYNPO2 ESS2 CTDSPL2 ARHGEF5 MAGEE1 KMT2E CIC TNRC18 NUP155 IGSF9B GAB1	4.80e-08	430	100	11	35044719
Pubmed	Human transcription factor protein interaction networks.	HSPG2 TCF4 ESS2 IRF2BP1 HMGXB4 GATA4 LARP1 MRPS35 SIX4 SRCAP CIC PHF2 DST ATXN1 RERE GARRE1 MOV10 SORL1	1.25e-07	1429	100	18	35140242
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	TCF4 TROAP ZNF185 KHDC4 CIC FAM222B GARRE1	3.02e-07	152	100	7	38360978
Pubmed	Over-expression of the chondroitin sulphate proteoglycan versican is associated with defective neural crest migration in the Pax3 mutant mouse (splotch).	HSPG2 ACAN PAX1	4.58e-07	6	100	3	9486530
Pubmed	Disruption of the ATXN1-CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humans.	SHANK3 CIC DLGAP3 ATXN1	7.77e-07	25	100	4	28288114
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	SGIP1 NRCAM MYCBP2 DVL1 DAG1 MRPS35 DGKG PLPPR3 SHROOM2 SHANK3 PDHX DLGAP3 TNRC18 TAB1 PLPPR2	9.16e-07	1139	100	15	36417873
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	TCF4 TBX3 ZNF185 SIX4 ZYX CIC IKZF4 HEYL LDB3 HOXC10 PER2 PAX1	9.61e-07	709	100	12	22988430
Pubmed	Cell-type specific regulator RBPMS switches alternative splicing via higher-order oligomerization and heterotypic interactions with other splicing regulators.	ESRP2 RBM47 RBFOX2	1.28e-06	8	100	3	37548402
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	NRIP1 TCF4 IRF2BP1 NELFA GATA4 PAPOLB CIC PHF2 HEYL PER2 PAX1 RERE RBFOX2	1.44e-06	877	100	13	20211142
Pubmed	A human MAP kinase interactome.	TBX3 SYNPO2 LAMA3 RAPGEF1 ZYX CIC DST ATXN1 GAB1 RBFOX2	1.46e-06	486	100	10	20936779
Pubmed	Hnf1b controls pancreas morphogenesis and the generation of Ngn3+ endocrine progenitors.	DAG1 DLL1 HEYL PKHD1	3.53e-06	36	100	4	25715395
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	TCF4 TBX3 HMGXB4 GATA4 SIX4 SRCAP DLL1 ZYX CIC PHF2 ATXN1 MBNL2	3.69e-06	808	100	12	20412781
Pubmed	The Dishevelled-associating protein Daple controls the non-canonical Wnt/Rac pathway and cell motility.	DVL1 CCDC88C	8.18e-06	2	100	2	22643886
Pubmed	Identification and characterization of a novel Dvl-binding protein that suppresses Wnt signalling pathway.	DVL1 CCDC88C	8.18e-06	2	100	2	14750955
Pubmed	ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology.	CIC ATXN1	8.18e-06	2	100	2	17190598
Pubmed	Exercise and genetic rescue of SCA1 via the transcriptional repressor Capicua.	CIC ATXN1	8.18e-06	2	100	2	22053053
Pubmed	Livebearing or egg-laying mammals: 27 decisive nucleotides of FAM168.	FAM168B FAM168A	8.18e-06	2	100	2	28381702
Pubmed	A native interactor scaffolds and stabilizes toxic ATAXIN-1 oligomers in SCA1.	CIC ATXN1	8.18e-06	2	100	2	25988806
Pubmed	Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cells.	CDH23 USH2A	8.18e-06	2	100	2	17360538
Pubmed	Expression microarray analysis reveals alternative splicing of LAMA3 and DST genes in head and neck squamous cell carcinoma.	LAMA3 DST	8.18e-06	2	100	2	24675808
Pubmed	Identification and characterization of novel genes located at the t(1;15)(p36.2;q24) translocation breakpoint in the neuroblastoma cell line NGP.	RERE SLC45A1	8.18e-06	2	100	2	10729226
Pubmed	A developmental transcriptomic analysis of Pax1 and Pax9 in embryonic intervertebral disc development.	HSPG2 ACAN PAX1	8.20e-06	14	100	3	28011632
Pubmed	Screening large numbers of expression patterns of transcription factors in late stages of the mouse thymus.	HMGXB4 ZYX CIC IKZF4 LDB3 HOXC10 PER2	1.15e-05	263	100	7	20932939
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	NRCAM SRCAP CIC PER2 GARRE1	1.30e-05	104	100	5	9205841
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	ESS2 DAG1 ESRP2 LLGL1 NUP155 RBM47	1.41e-05	180	100	6	35198878
Pubmed	The contribution of de novo coding mutations to autism spectrum disorder.	SRCAP PHF2 MOV10	1.82e-05	18	100	3	25363768
Pubmed	Sox5 and Sox6 are required for notochord extracellular matrix sheath formation, notochord cell survival and development of the nucleus pulposus of intervertebral discs.	HSPG2 ACAN PAX1	1.82e-05	18	100	3	12571105
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	TBX3 ARHGEF5 LARP1 TXLNA DST LLGL1 NUP155 RBM47 GARRE1 SORL1	1.86e-05	650	100	10	38777146
Pubmed	RBPjkappa-dependent Notch signaling regulates mesenchymal progenitor cell proliferation and differentiation during skeletal development.	DLL1 HEYL ACAN	2.16e-05	19	100	3	20335360
Pubmed	FOX-2 dependent splicing of ataxin-2 transcript is affected by ataxin-1 overexpression.	ATXN1 RBFOX2	2.45e-05	3	100	2	22666429
Pubmed	Disruption of the ATXN1-CIC complex reveals the role of additional nuclear ATXN1 interactors in spinocerebellar ataxia type 1.	CIC ATXN1	2.45e-05	3	100	2	36577402
Pubmed	Topographical variation in the distributions of versican, aggrecan and perlecan in the foetal human spine reflects their diverse functional roles in spinal development.	HSPG2 ACAN	2.45e-05	3	100	2	19669783
Pubmed	Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis.	CIC ATXN1	2.45e-05	3	100	2	20628574
Pubmed	Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1.	CIC ATXN1	2.45e-05	3	100	2	18337722
Pubmed	Signaling of hepatocyte growth factor/scatter factor (HGF) to the small GTPase Rap1 via the large docking protein Gab1 and the adapter protein CRKL.	RAPGEF1 GAB1	2.45e-05	3	100	2	10753869
Pubmed	Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function.	HSPG2 DAG1	2.45e-05	3	100	2	16098969
Pubmed	Dimerization leads to changes in APP (amyloid precursor protein) trafficking mediated by LRP1 and SorLA.	LRP1 SORL1	2.45e-05	3	100	2	28799085
Pubmed	Differential expression profiles between α-dystroglycan and integrin β1 in ameloblastoma: two possible perlecan signalling pathways for cellular growth and differentiation.	HSPG2 DAG1	2.45e-05	3	100	2	21255062
Pubmed	Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer.	ESRP2 RBFOX2	2.45e-05	3	100	2	27911856
Pubmed	Reciprocal expressions between α-dystroglycan and integrin β1, perlecan receptors, in the murine enamel organ development.	HSPG2 DAG1	2.45e-05	3	100	2	23722005
Pubmed	A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart.	LDB3 FAM168A MBNL2 RBFOX2	2.77e-05	60	100	4	19075228
Pubmed	DOT1L regulates dystrophin expression and is critical for cardiac function.	HSPG2 DAG1 LDB3	2.95e-05	21	100	3	21289070
Pubmed	Impaired fetal muscle development and JAK-STAT activation mark disease onset and progression in a mouse model for merosin-deficient congenital muscular dystrophy.	DAG1 DLL1 HEYL	3.41e-05	22	100	3	28334989
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	TCF4 ESS2 HMGXB4 GATA4 LARP1 SIX4 CIC ESRP2 LRP1 MOV10 SORL1	3.68e-05	857	100	11	25609649
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	MYCBP2 ARHGEF5 LARP1 ZYX CIC CCDC88C DST ATXN1 TAB1 GARRE1 GAB1	3.84e-05	861	100	11	36931259
Pubmed	In silico prediction of physical protein interactions and characterization of interactome orphans.	TCF4 RAPGEF1 LRP1 TAB1 GAB1	4.75e-05	136	100	5	25402006
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	IRF2BP1 LARP1 SIX4 CIC CCDC88C LLGL1 NUP155 SEC24C ATXN1	4.83e-05	583	100	9	29844126
Pubmed	An in situ hybridization study of perlecan, DMP1, and MEPE in developing condylar cartilage of the fetal mouse mandible and limb bud cartilage.	HSPG2 ACAN	4.89e-05	4	100	2	26428891
Pubmed	Disabled-2 is essential for endodermal cell positioning and structure formation during mouse embryogenesis.	GATA4 LRP1	4.89e-05	4	100	2	12413896
Pubmed	Dystroglycan protein distribution coincides with basement membranes and muscle differentiation during mouse embryogenesis.	LAMA3 DAG1	4.89e-05	4	100	2	17676646
Pubmed	Hairy-related transcription factors inhibit GATA-dependent cardiac gene expression through a signal-responsive mechanism.	GATA4 HEYL	4.89e-05	4	100	2	15485867
Pubmed	Perlecan is recruited by dystroglycan to nodes of Ranvier and binds the clustering molecule gliomedin.	HSPG2 DAG1	4.89e-05	4	100	2	25646087
Pubmed	The pro-neurotrophin receptor sortilin is a major neuronal apolipoprotein E receptor for catabolism of amyloid-β peptide in the brain.	LRP1 SORL1	4.89e-05	4	100	2	23283348
Pubmed	Analysis of HeyL expression in wild-type and Notch pathway mutant mouse embryos.	DLL1 HEYL	4.89e-05	4	100	2	11044625
Pubmed	Islet1 regulates establishment of the posterior hindlimb field upstream of the Hand2-Shh morphoregulatory gene network in mouse embryos.	TBX3 HOXC10 PAX1	5.07e-05	25	100	3	22438573
Pubmed	Bmp2 and Notch cooperate to pattern the embryonic endocardium.	TBX3 DLL1 HEYL	5.72e-05	26	100	3	29853617
Pubmed	Adamts18 modulates the development of the aortic arch and common carotid artery.	LAMA3 HEYL ACAN	5.72e-05	26	100	3	34189436
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	MAGEE1 KMT2E SHROOM2 SHANK3 STPG3 DST	5.98e-05	233	100	6	37704626
Pubmed	High glucose mediates the ChREBP/p300 transcriptional complex to activate proapoptotic genes Puma and BAX and contributes to intervertebral disc degeneration.	DVL1 GATA4 PHF2	7.98e-05	29	100	3	34461288
Pubmed	Ataxin-1 regulates B cell function and the severity of autoimmune experimental encephalomyelitis.	CIC ATXN1	8.14e-05	5	100	2	32878998
Pubmed	Disturbance of circadian gene expression in hepatocellular carcinoma.	ARHGEF5 PER2	8.14e-05	5	100	2	18444243
Pubmed	Cx30.2 enhancer analysis identifies Gata4 as a novel regulator of atrioventricular delay.	TBX3 GATA4	8.14e-05	5	100	2	19592579
Pubmed	Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family.	LRP1 SORL1	8.14e-05	5	100	2	17326667
Pubmed	Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake.	HSPG2 LRP1	8.14e-05	5	100	2	21289173
Pubmed	Developmental genetic bases behind the independent origin of the tympanic membrane in mammals and diapsids.	ACAN PAX1	8.14e-05	5	100	2	25902370
Pubmed	Interaction of the apolipoprotein E receptors low density lipoprotein receptor-related protein and sorLA/LR11.	LRP1 SORL1	8.14e-05	5	100	2	19047013
Pubmed	Vasculature-driven stem cell population coordinates tissue scaling in dynamic organs.	TBX3 ADAM8	8.14e-05	5	100	2	33568475
Pubmed	ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism.	CIC ATXN1	8.14e-05	5	100	2	29526553
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	NRIP1 MYCBP2 LAMA3 LARP1 SHROOM2 PHF2 TNRC18 FAM168A ATXN1 MBNL2 LRP1 IGSF9B RERE RBFOX2	9.22e-05	1489	100	14	28611215
Pubmed	Corticothalamic Projection Neuron Development beyond Subtype Specification: Fog2 and Intersectional Controls Regulate Intraclass Neuronal Diversity.	MYCBP2 GATA4 DMRT2	9.78e-05	31	100	3	27321927
Pubmed	Inflammation-dependent overexpression of c-Myc enhances CRL4DCAF4 E3 ligase activity and promotes ubiquitination of ST7 in colitis-associated cancer.	HSPG2 TCF4 CTC1 DVL1 CDH23 GAB1	1.02e-04	257	100	6	30945288
Pubmed	The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse.	TBX3 GATA4 DLL1	1.08e-04	32	100	3	23369715
Pubmed	Reevaluating human gene annotation: a second-generation analysis of chromosome 22.	HMGXB4 MCAT RBFOX2	1.18e-04	33	100	3	12529303
Pubmed	Deletion of Pax1 scoliosis-associated regulatory elements leads to a female-biased tail abnormality.	ACAN PAX1	1.22e-04	6	100	2	38461417
Pubmed	Systematic expression analysis of plasticity-related genes in mouse brain development brings PRG4 into play.	PLPPR3 PLPPR2	1.22e-04	6	100	2	34622503
Pubmed	Nuclear factor of activated T cells (NFAT) proteins repress canonical Wnt signaling via its interaction with Dishevelled (Dvl) protein and participate in regulating neural progenitor cell proliferation and differentiation.	TCF4 DVL1	1.22e-04	6	100	2	21880741
Pubmed	Mesenchymal stromal cell-derived septoclasts resorb cartilage during developmental ossification and fracture healing.	DLL1 ACAN	1.22e-04	6	100	2	35091558
Pubmed	De novo gene disruptions in children on the autistic spectrum.	DLL1 CIC	1.22e-04	6	100	2	22542183
Pubmed	Differential Notch signaling in the epicardium is required for cardiac inflow development and coronary vessel morphogenesis.	GATA4 DLL1 HEYL	1.29e-04	34	100	3	21311046
Pubmed	Transcriptional analysis of cleft palate in TGFβ3 mutant mice.	HSPG2 NRCAM PAX1	1.41e-04	35	100	3	32913205
Pubmed	A cellular and molecular mosaic establishes growth and differentiation states for cranial sensory neurons.	TBX3 SIX4 DLL1	1.41e-04	35	100	3	26988119
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	ESS2 IRF2BP1 MYCBP2 NELFA SCYL3 DAG1 KHDC4 TXLNA TAB1 MOV10 RBFOX2	1.54e-04	1007	100	11	34597346
Pubmed	Hey basic helix-loop-helix transcription factors are repressors of GATA4 and GATA6 and restrict expression of the GATA target gene ANF in fetal hearts.	GATA4 HEYL	1.70e-04	7	100	2	16199874
Pubmed	Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm.	DLL1 PAX1	1.70e-04	7	100	2	9153393
Pubmed	Biochemical characterization of native Usher protein complexes from a vesicular subfraction of tracheal epithelial cells.	CDH23 USH2A	1.70e-04	7	100	2	20058854
Pubmed	Mouse mutant "rib-vertebrae" (rv): a defect in somite polarity.	DLL1 PAX1	1.70e-04	7	100	2	11002339
Pubmed	Oscillating expression of c-Hey2 in the presomitic mesoderm suggests that the segmentation clock may use combinatorial signaling through multiple interacting bHLH factors.	TCF4 DLL1	1.70e-04	7	100	2	11076679
Pubmed	Postnatal regulation of B-1a cell development and survival by the CIC-PER2-BHLHE41 axis.	CIC PER2	1.70e-04	7	100	2	35172136
Pubmed	Positive regulation of myogenic bHLH factors and skeletal muscle development by the cell surface receptor CDO.	PAX1 CDON	1.70e-04	7	100	2	15572127
Pubmed	Hey bHLH Proteins Interact with a FBXO45 Containing SCF Ubiquitin Ligase Complex and Induce Its Translocation into the Nucleus.	MYCBP2 HEYL	1.70e-04	7	100	2	26068074
Pubmed	Early mesodermal phenotypes in splotch suggest a role for Pax3 in the formation of epithelial somites.	DLL1 PAX1	1.70e-04	7	100	2	11747084
Pubmed	Proline-rich synapse-associated proteins ProSAP1 and ProSAP2 interact with synaptic proteins of the SAPAP/GKAP family.	SHANK3 DLGAP3	1.70e-04	7	100	2	10527873
Pubmed	Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice.	HSPG2 DAG1	1.70e-04	7	100	2	11802174
Pubmed	Double deletion of melanocortin 4 receptors and SAPAP3 corrects compulsive behavior and obesity in mice.	TCF4 DLGAP3	1.70e-04	7	100	2	23754400
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NRCAM SEC24C PER2 FAM168A ZFR2 RERE ULK2	1.80e-04	407	100	7	12693553
Pubmed	Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation.	HSPG2 SYNPO2 DAG1 ZYX DST LRP1	1.80e-04	285	100	6	21423176
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	LARP1 ZYX PDHX CCDC88C SEC24C TAB1 MOV10 RBFOX2	1.96e-04	551	100	8	34728620
Pubmed	The microRNA-processing enzyme Dicer is dispensable for somite segmentation but essential for limb bud positioning.	TBX3 DLL1 HOXC10	2.11e-04	40	100	3	21256124
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	NRIP1 MYCBP2 DVL1 CIC DST LRP1 RERE	2.11e-04	418	100	7	34709266
Interaction	NTRK2 interactions	SGIP1 DVL1 PLPPR3 DST LLGL1 LRP1 GAB1 SORL1	2.33e-06	176	98	8	int:NTRK2
Interaction	EYA4 interactions	TCF4 TROAP ZNF185 SIX4 KHDC4 CIC NUP155 FAM222B GARRE1	2.88e-06	243	98	9	int:EYA4
Interaction	TOP3B interactions	HSPG2 MYCBP2 CTC1 DVL1 RAPGEF1 SRCAP DLL1 FBXO46 CIC ESRP2 CCDC88C HEYL TNRC18 DST PER2 NBEAL2 SLC45A1 RBM47 ULK2 MOV10	2.23e-05	1470	98	20	int:TOP3B
Cytoband	1p36.23	RERE SLC45A1	4.20e-04	14	100	2	1p36.23
Cytoband	22q13.1	HMGXB4 TAB1 RBFOX2	8.70e-04	85	100	3	22q13.1
GeneFamily	Phospholipid phosphatase related	PLPPR3 PLPPR2	1.19e-04	5	63	2	1127
GeneFamily	PDZ domain containing	SYNPO2 DVL1 SHROOM2 SHANK3 LDB3	1.87e-04	152	63	5	1220
GeneFamily	Fibronectin type III domain containing	NRCAM IGSF9B USH2A CDON SORL1	2.37e-04	160	63	5	555
GeneFamily	LIM domain containing	ZNF185 ZYX LDB3	1.14e-03	59	63	3	1218
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	GATA4 RERE	1.22e-03	15	63	2	82
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	HSPG2 NRCAM IGSF9B CDON	2.40e-03	161	63	4	593
GeneFamily	Immunoglobulin like domain containing	HSPG2 NRCAM IGSF9B CDON	4.59e-03	193	63	4	594
Coexpression	ONDER_CDH1_TARGETS_2_DN	AMPD3 NRCAM ARHGEF5 ZNF185 LAMA3 ADAM8 ESRP2 DST MALL NBEAL2 RBM47 SORL1	2.32e-07	473	99	12	M4306
Coexpression	GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP	TCF4 AMPD3 KMT2E CCDC88C CD6 GARRE1 CDON	1.12e-05	200	99	7	M5711
Coexpression	LIM_MAMMARY_STEM_CELL_UP	HSPG2 TCF4 SGIP1 NRCAM TTYH2 LAMA3 RAPGEF1 DLL1 DST LRP1	1.38e-05	479	99	10	M2573
Coexpression	LIM_MAMMARY_STEM_CELL_UP	HSPG2 TCF4 SGIP1 NRCAM TTYH2 LAMA3 RAPGEF1 DLL1 DST LRP1	1.48e-05	483	99	10	MM1082
Coexpression	GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP	NRIP1 FAM168B NELFA ESRP2 PHF2 ACAN	2.39e-05	151	99	6	M421
Coexpression	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	NRIP1 NRCAM PLPPR3 LILRB1 ATXN1 MALL	3.19e-05	159	99	6	M12138
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	LARP1 SRCAP SEC31B KHDC4 FBXO46 CIC HEYL LLGL1	4.35e-05	338	99	8	M17094
Coexpression	VERRECCHIA_EARLY_RESPONSE_TO_TGFB1	HSPG2 DVL1 ZYX LRP1	5.24e-05	54	99	4	M4737
Coexpression	SINGH_KRAS_DEPENDENCY_SIGNATURE	AMPD3 LAMA3 ADAM8	5.69e-05	20	99	3	M2851
Coexpression	XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_669C_3P_GENES	FAM168B ZNF185 LARP1 RAPGEF1 LDB3 LLGL1	6.98e-05	183	99	6	MM17506
Coexpression	DCA_UP.V1_DN	IRF2BP1 LAMA3 TXLNA TNRC18 FAM222B CDON	7.41e-05	185	99	6	M2760
Coexpression	PGF_UP.V1_DN	IRF2BP1 TROAP ZNF185 GATA4 SRCAP ZFR2	8.59e-05	190	99	6	M2673
Coexpression	WONG_ADULT_TISSUE_STEM_MODULE	NRIP1 TCF4 AMPD3 NRCAM ARHGEF5 DGKG KMT2E SHANK3 DST NBEAL2 SORL1	8.86e-05	721	99	11	M1999
Coexpression	GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_UP	FAM168B CTC1 SCYL3 FBXO46 SEC24C GARRE1	9.36e-05	193	99	6	M3487
Coexpression	GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_DN	IRF2BP1 MAGEE1 ADAM8 FBXO46 CD6 GARRE1	1.02e-04	196	99	6	M6073
Coexpression	GSE360_L_DONOVANI_VS_T_GONDII_MAC_UP	AMPD3 ZNF185 PDHX ZFR2 TAB1 USH2A	1.11e-04	199	99	6	M5233
Coexpression	GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP	SRCAP KHDC4 ZYX HOXC10 DMRT2 NBEAL2	1.14e-04	200	99	6	M9391
Coexpression	GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_UP	LAMA3 PAPOLB ADAM8 STPG3 RBM47 ULK2	1.14e-04	200	99	6	M8097
Coexpression	GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_DN	NRIP1 HMGXB4 SRCAP KMT2E CCDC88C DMRT2	1.14e-04	200	99	6	M9315
Coexpression	GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP	TTYH2 SEC24C ATXN1 NBEAL2 PKHD1 IGSF9B	1.14e-04	200	99	6	M6514
Coexpression	GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP	HMGXB4 SRCAP KHDC4 CCDC88C RERE SORL1	1.14e-04	200	99	6	M8500
Coexpression	GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP	NRIP1 CIC IKZF4 PER2 FAM168A SORL1	1.14e-04	200	99	6	M9205
Coexpression	KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_UP	TCF4 AMPD3 MYCBP2 DVL1 SRCAP RERE	1.14e-04	200	99	6	M3012
Coexpression	GSE19825_IL2RALOW_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP	NRIP1 SCYL3 ZYX MBNL2 RERE SORL1	1.14e-04	200	99	6	M4301
CoexpressionAtlas	DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_1000	TBX3 AMPD3 SYNPO2 MYCBP2 LAMA3 SIX4 ESRP2 DST NUP155 PTGR1 NBEAL2 PKHD1 RBM47 RBFOX2 SORL1	3.39e-06	784	99	15	gudmap_developingLowerUrinaryTract_e15.5_urothelium_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000	TBX3 LAMA3 ESRP2 DST MALL SORL1	1.15e-05	108	99	6	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000	TCF4 TBX3 SYNPO2 SGIP1 CTDSPL2 LAMA3 KMT2E ESRP2 DST NUP155 MBNL2 MALL RBFOX2 SORL1	1.30e-05	769	99	14	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000	NRIP1 TBX3 AMPD3 MYCBP2 CTDSPL2 SIX4 SRCAP ESRP2 NUP155 NBEAL2 PKHD1 RBM47 RBFOX2 SORL1	1.40e-05	774	99	14	gudmap_developingKidney_e15.5_cortic collect duct_1000
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500	NRIP1 HMGXB4 KMT2E FAM222B RBFOX2	1.42e-05	66	99	5	gudmap_developingGonad_e11.5_ovary + mesonephros_k2_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000	NRIP1 TBX3 SYNPO2 ZNF185 LAMA3 SIX4 ESRP2 DST PTGR1 NBEAL2 PKHD1 RBM47 GAB1 SORL1	1.53e-05	780	99	14	gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_500	TBX3 AMPD3 MYCBP2 LAMA3 ESRP2 DST PKHD1 RBM47 RBFOX2 SORL1	1.55e-05	394	99	10	gudmap_developingLowerUrinaryTract_e15.5_urothelium_500
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000	SGIP1 NRCAM MYCBP2 CTDSPL2 SIX4 DLL1 ESRP2 HOXC10 DST PKHD1 RBM47 GARRE1 RBFOX2 SORL1	1.89e-05	795	99	14	gudmap_developingKidney_e15.5_anlage of loop of Henle_1000
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#1_top-relative-expression-ranked_1000	NRIP1 HMGXB4 TTYH2 GATA4 DAG1 KMT2E FAM222B	2.32e-05	182	99	7	gudmap_developingGonad_e16.5_ovary_1000_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#3_top-relative-expression-ranked_500	ESRP2 PTGR1 PKHD1 RBM47 SORL1	6.06e-05	89	99	5	gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_500_k3
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#2_top-relative-expression-ranked_1000	NRIP1 TBX3 AMPD3 ESRP2 NBEAL2 SORL1	7.90e-05	152	99	6	gudmap_developingKidney_e15.5_cortic collect duct_1000_k2
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000	NRIP1 HMGXB4 DAG1 SRCAP KMT2E IKZF4 TNRC18 ATXN1 MBNL2 PKHD1 LRP1 RBFOX2 CDON	8.59e-05	799	99	13	gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000	HMGXB4 GATA4 DAG1 KMT2E FAM222B RBFOX2	9.11e-05	156	99	6	gudmap_developingGonad_e11.5_ovary + mesonephros_k4_1000
CoexpressionAtlas	DevelopingGonad_P2_testes_emap-30171_k-means-cluster#4_top-relative-expression-ranked_1000	TTYH2 GATA4 DAG1 CDH23 ZYX DST MBNL2 MOV10	1.24e-04	319	99	8	gudmap_developingGonad_P2_testes_1000_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#2_top-relative-expression-ranked_1000	TBX3 ESRP2 PTGR1 PKHD1 RBM47 SORL1	1.32e-04	167	99	6	gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000_k2
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500	NRIP1 HMGXB4 SRCAP KMT2E TNRC18 DMRT2 LRP1 RBFOX2 CDON	1.35e-04	413	99	9	gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_1000	GATA4 DAG1 TNRC18 DST PTGR1 MOV10	1.46e-04	170	99	6	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k4_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_1000	TBX3 LAMA3 ESRP2 DST SORL1	1.52e-04	108	99	5	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k5
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_1000	ZNF185 GATA4 TNRC18 PTGR1 MOV10	1.80e-04	112	99	5	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k1_1000
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000	ZNF185 TTYH2 GATA4 DAG1 LARP1 CDH23 TNRC18 DST PTGR1 MALL GARRE1 GAB1 MOV10	2.33e-04	884	99	13	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000	TCF4 SGIP1 CTDSPL2 SIX4 SRCAP SLC7A6 KHDC4 CCDC88C HEYL HOXC10 NUP155 RBFOX2	2.71e-04	779	99	12	gudmap_developingKidney_e15.5_Cap mesenchyme_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	NRIP1 HMGXB4 DAG1 SRCAP KMT2E IKZF4 TNRC18 HOXC10 ATXN1 LRP1 RBFOX2 CDON	3.08e-04	790	99	12	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#2_top-relative-expression-ranked_1000	HMGXB4 GATA4 DAG1 KMT2E GARRE1	3.11e-04	126	99	5	gudmap_developingGonad_e14.5_ ovary_1000_k2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#3	ARHGEF5 ZNF185 ESRP2 HEYL MBNL2 NBEAL2 MOV10	3.19e-04	277	99	7	Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K3
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	NRIP1 HMGXB4 DAG1 SRCAP KMT2E IKZF4 TNRC18 DMRT2 PKHD1 LRP1 RBFOX2 CDON	3.49e-04	801	99	12	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#4_top-relative-expression-ranked_1000	AMPD3 SYNPO2 PTGR1 PKHD1 RBM47	3.99e-04	133	99	5	gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k4
CoexpressionAtlas	gudmap_RNAseq_e11.5_Ureteric_bud_2500_K0	TBX3 AMPD3 NRCAM ARHGEF5 LAMA3 ESRP2 PTGR1 MALL NBEAL2 PKHD1 RBM47	4.77e-04	711	99	11	gudmap_RNAseq_e11.5_Ureteric_bud_2500_K0
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_500	SYNPO2 ESRP2 DST PTGR1 NBEAL2 PKHD1 RBM47 SORL1	4.90e-04	391	99	8	gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_500
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_100	ESRP2 NBEAL2 PKHD1 RBM47	5.11e-04	79	99	4	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_100
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000	TCF4 TBX3 SGIP1 DGKG DLL1 PHF2 DMRT2 PTGR1 ATXN1 MBNL2 ZFR2 ULK2 PLPPR2	5.81e-04	973	99	13	Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000
CoexpressionAtlas	mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K1	LAMA3 DAG1 PTGR1 MALL NBEAL2 PKHD1 RBM47 SORL1	5.88e-04	402	99	8	mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5	NRCAM SLC36A4 MAGEE1 KMT2E DLL1 PHF2 CCDC88C DST FAM168A ATXN1 PLPPR2	6.07e-04	732	99	11	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5
ToppCell	Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TBX3 SGIP1 NRCAM DGKG SHROOM2 HEYL DST DMRT2	1.67e-08	199	100	8	929f809579368201331d9099d8904b6e3c41797b
ToppCell	Bronchial-NucSeq-Stromal-Pericyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TBX3 SGIP1 NRCAM DGKG SHROOM2 HEYL DST DMRT2	1.67e-08	199	100	8	854628ce91068093c14bd4d45ba38c41469f3549
ToppCell	proximal-3-mesenchymal-Pericyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TCF4 TBX3 SGIP1 NRCAM TTYH2 DGKG HEYL DMRT2	1.74e-08	200	100	8	98cbd0f4994e645f70c0bc5ebc1c3a3b28c6b67f
ToppCell	proximal-mesenchymal-Pericyte\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TCF4 TBX3 SGIP1 NRCAM TTYH2 DGKG HEYL DMRT2	1.74e-08	200	100	8	03119a979bc912a98e6fc87addcbc25d8ecf2fb0
ToppCell	proximal-mesenchymal-Pericyte-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TCF4 TBX3 SGIP1 NRCAM TTYH2 DGKG HEYL DMRT2	1.74e-08	200	100	8	a81fde3d40b8efb3be535aeb2a44cfbdeb17bc8b
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TBX3 SGIP1 NRCAM DGKG SHROOM2 HEYL LDB3	1.77e-07	181	100	7	451b87ac95154bb80018b8dd245b4a6389d81411
ToppCell	Pericytes-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	SYNPO2 SGIP1 NRCAM DGKG HEYL LDB3 ACAN	1.91e-07	183	100	7	4617b18da8d699a44e4c47980197b1e7eb951470
ToppCell	Adult-Mesenchymal-pericyte_cell\|Adult / Lineage, Cell type, age group and donor	TBX3 SGIP1 NRCAM TTYH2 DGKG HEYL LDB3	2.21e-07	187	100	7	62759efb660179402fb574ce5701c89a2e17bcfe
ToppCell	Mesenchymal-pericyte_cell\|World / Lineage, Cell type, age group and donor	TBX3 SGIP1 NRCAM TTYH2 DGKG HEYL DMRT2	2.38e-07	189	100	7	d7ed96add29f219183c802895fbff519b627f635
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 SGIP1 DGKG HEYL LDB3 ACAN IGSF9B	2.55e-07	191	100	7	04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	HSPG2 TCF4 CDH23 RAPGEF1 SHANK3 MALL GARRE1	2.55e-07	191	100	7	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	renal_papilla_nuclei-Adult_normal_reference\|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 TBX3 SYNPO2 NRCAM SLC7A6 SHROOM2 PTGR1	2.64e-07	192	100	7	6c106b91e46eabbe686a52a65a9c94ad9cbe9390
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TBX3 SYNPO2 SGIP1 DGKG HEYL LDB3 ACAN	3.04e-07	196	100	7	8c25fa61c117a60ddd4cbd2f95ae5b66f986a1ec
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TCF4 TBX3 SGIP1 NRCAM DGKG HEYL LDB3	3.15e-07	197	100	7	f66945f9007d59d4208849c7fd727f8519713fbc
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TBX3 SYNPO2 SGIP1 NRCAM DGKG HEYL LDB3	3.15e-07	197	100	7	01249bd485a3734de87ae6ed9c749597f39c6335
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TCF4 TBX3 SGIP1 NRCAM DGKG HEYL LDB3	3.15e-07	197	100	7	41dd312f46a2b983c8d864adeb6970c0ca4a8048
ToppCell	Control-Epithelial_alveolar-Mes-Like-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TTYH2 LAMA3 ADAM8 HEYL SEC24C CDON	4.31e-07	127	100	6	556aaf88719c83f307fa50dfac151136ed05c8ad
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	NRCAM LAMA3 DGKG ESRP2 RBM47 SORL1	2.13e-06	167	100	6	25af48c640e67848594f5902867ba325fc105da4
ToppCell	Adult-Mesenchymal-pericyte_cell-D175\|Adult / Lineage, Cell type, age group and donor	SGIP1 NRCAM TTYH2 DGKG HEYL LDB3	2.62e-06	173	100	6	fd6653d6be9ca6ac36798590694efe03cb758c67
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 DGKG HEYL LDB3 ACAN IGSF9B	2.80e-06	175	100	6	d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 DGKG HEYL LDB3 ACAN IGSF9B	2.80e-06	175	100	6	454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	SYNPO2 SGIP1 DGKG HEYL LDB3 IGSF9B	3.29e-06	180	100	6	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	Pericytes-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	SYNPO2 NRCAM PAPOLB HEYL LDB3 ACAN	3.40e-06	181	100	6	35c470988a93381eefa300831aabb813fa1b90bd
ToppCell	Adult-Mesenchymal-pericyte_cell-D122\|Adult / Lineage, Cell type, age group and donor	TBX3 SGIP1 NRCAM DGKG HEYL LDB3	3.62e-06	183	100	6	fc31a43a637423cb3bb9aa184a3a889a0b9aaea6
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	LAMA3 DGKG ESRP2 PKHD1 RBM47 SORL1	3.74e-06	184	100	6	fa4915b0498f3069fd5ef497286445528f75187e
ToppCell	COVID-19-Fibroblasts-Pericytes\|COVID-19 / group, cell type (main and fine annotations)	TBX3 SGIP1 NRCAM DGKG HEYL LDB3	3.85e-06	185	100	6	4905adaeeffd353e089578e5ea614437dbe794e6
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 TBX3 SYNPO2 DGKG MBNL2 LRP1	4.10e-06	187	100	6	d591a3c216997663ab77710fed0d230ffc37e41a
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 SYNPO2 PAPOLB HEYL LDB3 IGSF9B	4.10e-06	187	100	6	218c9b4f28499389c43005d9626af2ac01066027
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TBX3 SGIP1 NRCAM DGKG HEYL LDB3	4.10e-06	187	100	6	86250acf088ec0c4800a0dfa031b0d4f7e52c342
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 TBX3 SYNPO2 DGKG MBNL2 LRP1	4.10e-06	187	100	6	d1dc8c9a2c2cd10c640257161a75e7730ec5bb41
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 TBX3 SYNPO2 DGKG MBNL2 LRP1	4.10e-06	187	100	6	ac8e092b37e042975e2ee057d3f7c6821e58e8b5
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SGIP1 NRCAM TTYH2 DGKG HEYL DMRT2	4.10e-06	187	100	6	a2bf958ea59c359a265bfa437d59315e1920cdd4
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 SYNPO2 PAPOLB HEYL LDB3 IGSF9B	4.10e-06	187	100	6	c7ac4b328efc2ebb72f71154661914193ff402ca
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TBX3 SGIP1 NRCAM DGKG HEYL LDB3	4.23e-06	188	100	6	ee151792c7ac9afe820f1a281c6dab383799f358
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NRCAM LAMA3 DGKG PKHD1 RBM47 SORL1	4.36e-06	189	100	6	5d9da836ce4308b8458bb3be3871a0aca734b6cd
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	HSPG2 TCF4 RAPGEF1 SHROOM2 SHANK3 GARRE1	4.36e-06	189	100	6	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	HSPG2 TCF4 RAPGEF1 SHROOM2 SHANK3 GARRE1	4.36e-06	189	100	6	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NRCAM LAMA3 DGKG PKHD1 RBM47 SORL1	4.49e-06	190	100	6	625c08a0e5227efc46daa512fd579c3938ff76c7
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SYNPO2 DGKG HEYL LDB3 ACAN IGSF9B	4.49e-06	190	100	6	73d94fbae92029745989a8712eed8b99fd84c193
ToppCell	COVID-19-kidney-vSMC/Pericyte\|kidney / Disease (COVID-19 only), tissue and cell type	SYNPO2 SGIP1 DGKG HEYL LDB3 ACAN	4.63e-06	191	100	6	fad8eaa536001b911d05ae2b12150c2398cc6f88
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 DGKG HEYL LDB3 ACAN IGSF9B	4.77e-06	192	100	6	bfab13793e54de2550ee171397f7ece0625cdb4a
ToppCell	RA-09._Endothelium_I\|RA / Chamber and Cluster_Paper	HSPG2 TCF4 CDH23 RAPGEF1 SHANK3 GARRE1	4.77e-06	192	100	6	8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 DGKG HEYL LDB3 ACAN IGSF9B	4.77e-06	192	100	6	b54b0d5b88139905521c8d5d58332e89c08d589c
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NRCAM LAMA3 DGKG PKHD1 RBM47 SORL1	4.77e-06	192	100	6	b7c01e12b3e9be960a741b08835f1dfff65d0d47
ToppCell	RV-10._Endothelium_II\|RV / Chamber and Cluster_Paper	HSPG2 TCF4 RAPGEF1 SHROOM2 SHANK3 GARRE1	4.92e-06	193	100	6	01c2df9206f1527c578e808978e58196c35e72f5
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RAPGEF1 FAM168A ATXN1 RERE RBM47 RBFOX2	4.92e-06	193	100	6	779276e775cb2492e8dd36436295a536084a6415
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TBX3 SYNPO2 NRCAM DGKG HEYL LDB3	4.92e-06	193	100	6	000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	HSPG2 TCF4 RAPGEF1 SHROOM2 SHANK3 GARRE1	4.92e-06	193	100	6	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-myofibroblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	DAG1 SIX4 HEYL HOXC10 DMRT2 RBFOX2	4.92e-06	193	100	6	02dfd1df1e7fc84bfca2b0c95138b5b4408bb5d1
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 DGKG HEYL LDB3 ACAN IGSF9B	5.06e-06	194	100	6	5c3b2b05d1e4f146551fe4c920263d8e6ca34de3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 DGKG HEYL LDB3 ACAN IGSF9B	5.06e-06	194	100	6	ab9cad697f9209d2889bc02b43b502dfeb2ebfef
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TBX3 SYNPO2 NRCAM DGKG PLPPR3 HEYL	5.06e-06	194	100	6	67f5e2f05a8de2213ab80d5ea16fdee121684633
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|lung / Disease (COVID-19 only), tissue and cell type	SYNPO2 SGIP1 DGKG HEYL LDB3 ACAN	5.06e-06	194	100	6	5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 TCF4 LAMA3 RAPGEF1 SHANK3 GARRE1	5.22e-06	195	100	6	d35102f95bb1e419d2df05ff0a01b6c5c923acef
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYNPO2 SGIP1 LAMA3 DGKG HEYL LDB3	5.69e-06	198	100	6	b7e900fc0a1b3fa5e47dcc36ce6b0c3ce6bf9739
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	DAG1 SIX4 HEYL HOXC10 DMRT2 RBFOX2	5.86e-06	199	100	6	e19b296d583f8bad3b66ee998a8153634d6fe09e
ToppCell	PBMC-Control-cDC_0\|Control / Compartment, Disease Groups and Clusters	LILRB1 ATXN1 NBEAL2 LRP1 RBM47 SORL1	5.86e-06	199	100	6	ebf03979ef56e978d72db475bb635b43b9cbe402
ToppCell	Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SYNPO2 SGIP1 LAMA3 LDB3 HOXC10 ACAN	5.86e-06	199	100	6	78a9b26215874a46a910a4b93a51fcac1a597618
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	DAG1 SIX4 HEYL HOXC10 DMRT2 RBFOX2	5.86e-06	199	100	6	801887db51ac5dc5b068808ff75e3a46643398e9
ToppCell	distal-3-mesenchymal-Pericyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TBX3 SGIP1 NRCAM DGKG HEYL DMRT2	6.03e-06	200	100	6	911db29f254bb697610e720ba78816e2c7f57933
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	TCF4 TBX3 SGIP1 NRCAM DGKG HEYL	6.03e-06	200	100	6	0c648941447c738caf62f2d71e296d6cca492c8b
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYNPO2 SGIP1 DGKG HEYL LDB3 IGSF9B	6.03e-06	200	100	6	a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TCF4 TBX3 SGIP1 NRCAM DGKG HEYL	6.03e-06	200	100	6	522a51a284d2992d519c4669e1a48c8ebcc08c80
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	TCF4 TBX3 SGIP1 NRCAM DGKG HEYL	6.03e-06	200	100	6	94f1fa61aa82eb9f411b2b1cb759476939ab5db7
ToppCell	Parenchymal-10x5prime-Stromal-Pericyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TBX3 SGIP1 NRCAM DGKG HEYL DMRT2	6.03e-06	200	100	6	0a7640db28c708003d5da2d19eb651f6fedfd710
ToppCell	Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	NRIP1 SGIP1 DLL1 DST GARRE1	2.11e-05	148	100	5	f90ee6fbd71b5e0512af34867202f38409f4de38
ToppCell	E16.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SYNPO2 DGKG LILRB1 NBEAL2 SORL1	2.47e-05	153	100	5	6a2a2379238133ce0ad714af130ffe02dd317247
ToppCell	E16.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SYNPO2 DGKG LILRB1 NBEAL2 SORL1	2.47e-05	153	100	5	faa442dd925b2b09919e93c492ccc3f19803ad24
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 SGIP1 DGKG HEYL LDB3	3.76e-05	167	100	5	e228b8373ffd4436e6b944e26d0fadf3ac289b21
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 SGIP1 DGKG HEYL LDB3	3.76e-05	167	100	5	7cb1b11e8e24a10115e46ffbb74889e672a7a026
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 SGIP1 DGKG HEYL LDB3	3.76e-05	167	100	5	bb53a478b5d821d6d82c15bc4ed075b67682457c
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TCF4 LAMA3 DST TAB1 GARRE1	3.98e-05	169	100	5	665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TCF4 LAMA3 DST TAB1 GARRE1	3.98e-05	169	100	5	6614c9851537e4c21b1e45ff0cc3bad07ef9d034
ToppCell	3'-Adult-LymphNode-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNPO2 DGKG AQP7B HEYL LDB3	4.82e-05	176	100	5	56e19240f4a7b617a986e3c0854b757394e78251
ToppCell	3'-Adult-LymphNode-Mesenchymal-Pericytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNPO2 DGKG AQP7B HEYL LDB3	4.82e-05	176	100	5	c88b46fe29ae7606c8880a6ff0ebb85c0dfda8bd
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TBX3 SGIP1 NRCAM DGKG HEYL	4.96e-05	177	100	5	452ec2df36c6d656a7cdadc55be545ccdb146a29
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPG2 LAMA3 NBEAL2 PKHD1 RBM47	4.96e-05	177	100	5	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TBX3 SGIP1 NRCAM DGKG HEYL	5.09e-05	178	100	5	185b44700f06ec58b3c09c80520502166c965fd6
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SYNPO2 DGKG HEYL LDB3 ACAN	5.09e-05	178	100	5	066dbc4cc2083c549d98122ed44707127f34d582
ToppCell	Endothelial-A-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	TCF4 TBX3 PAPOLB SHANK3 GARRE1	5.09e-05	178	100	5	2f2602b9305d55f25afa9861dd6c6347ae179337
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TBX3 SGIP1 NRCAM DGKG HEYL	5.23e-05	179	100	5	dc6cd46fa652b296ddbc41855f6377946d0a4cdc
ToppCell	droplet-Fat-Gat-18m-Endothelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRIP1 SGIP1 CDH23 MALL NBEAL2	5.23e-05	179	100	5	08cf9986804a6417a9afb19b50c69a3554f71ec6
ToppCell	droplet-Liver-LIVER_HEP-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 MYCBP2 KMT2E SHANK3 DMRT2	5.37e-05	180	100	5	dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell	droplet-Liver-LIVER_HEP\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 MYCBP2 KMT2E SHANK3 DMRT2	5.37e-05	180	100	5	423454e3390080ae03bb3cbb267255ebfe4df080
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RAPGEF1 LILRB1 ATXN1 MBNL2 GAB1	5.66e-05	182	100	5	626aabfd9ac662c1d189f7c4b660482914d9e669
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNPO2 ZNF185 DGKG ZYX CDON	5.66e-05	182	100	5	7b86703559438e2d5ef3dad963ee0d772513f313
ToppCell	Pericytes-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	SYNPO2 DGKG HEYL LDB3 ACAN	5.66e-05	182	100	5	46c213597445b1f4f09dc367f27702d24b201daf
ToppCell	pdx-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	TCF4 NRCAM DGKG SLC7A6 RERE	5.66e-05	182	100	5	7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RAPGEF1 LILRB1 ATXN1 MBNL2 GAB1	5.66e-05	182	100	5	a00abff41c12b71d5860c494b8c722d649fd5f36
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	TBX3 SYNPO2 NRCAM LDB3 IGSF9B	5.80e-05	183	100	5	a1d4f25e13f5b9e92a9ca0a804a7bed5df8fb2fe
ToppCell	Basal\|World / shred by cell class for mouse tongue	LAMA3 SLC7A6 DLL1 ZYX DST	5.80e-05	183	100	5	c6729a207526ff4aa48176207b9353176f631fea
ToppCell	5'-Adult-LymphNode-Mesenchymal-myocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNPO2 LDB3 ULK2 PLPPR2 CDON	5.80e-05	183	100	5	d67454baf0cf791a743b51afd1cb25bfb5765385
ToppCell	5'-Adult-LymphNode-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNPO2 LDB3 ULK2 PLPPR2 CDON	5.80e-05	183	100	5	e49ac8314b6fe98426b1514ea68d646297b8bc0f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 SGIP1 DGKG HEYL LDB3	6.11e-05	185	100	5	51dfe6ac7df8b330343b37e3bee71e5c65267189
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SGIP1 TTYH2 DGKG HEYL DMRT2	6.11e-05	185	100	5	a7dba7db79275884b2a93d8a16f2e0c739e71370
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_2\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HSPG2 TCF4 AMPD3 TTYH2 ADAM8	6.11e-05	185	100	5	fec16a5e527fdef32d25957451b6e8ee9796cafd
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 SGIP1 DGKG HEYL LDB3	6.11e-05	185	100	5	a8c02cec3c414f3a0da9f2d6d28ce563b0030705
ToppCell	(5)_Pericytes\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	TBX3 SYNPO2 SGIP1 HEYL LDB3	6.27e-05	186	100	5	acbca8cc048d87faf859b3e77bdb38d0a3dad71c
ToppCell	(5)_Pericytes-(50)_Pericytes\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	TBX3 SYNPO2 SGIP1 HEYL LDB3	6.27e-05	186	100	5	67b59defdd1ed3608229cc5e2a3b480d92312afa
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TBX3 SGIP1 NRCAM DGKG HEYL	6.27e-05	186	100	5	888e85a025bd982d36c910db0f5a3385b1ca3b28
Drug	Homosalate [118-56-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A	ESS2 GATA4 FAM168A MBNL2 SMPD1 TAB1 ULK2 PLPPR2	2.38e-06	197	99	8	4355_DN
Drug	Proadifen hydrochloride [62-68-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A	IRF2BP1 HMGXB4 SRCAP PHF2 SMPD1 PLPPR2 RBFOX2 SORL1	2.66e-06	200	99	8	7165_DN
Drug	TTNPB; Up 200; 0.1uM; MCF7; HG-U133A	NRIP1 TBX3 LAMA3 DGKG SRCAP CD6 PAX1	1.97e-05	190	99	7	223_UP
Drug	Nifedipine [21829-25-4]; Up 200; 11.6uM; PC3; HT_HG-U133A	HSPG2 IRF2BP1 FBXO46 CCDC88C CD6 MBNL2 ACAN	2.25e-05	194	99	7	7303_UP
Drug	17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A	NRIP1 IRF2BP1 LAMA3 SHROOM2 CCDC88C MCAT RERE	2.25e-05	194	99	7	6933_DN
Drug	(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; MCF7; HT_HG-U133A	HSPG2 IRF2BP1 SRCAP CIC SMPD1 RERE GARRE1	2.25e-05	194	99	7	3384_DN
Drug	Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; HL60; HT_HG-U133A	HSPG2 NRIP1 TCF4 SEC31B CD6 TAB1 RBFOX2	2.25e-05	194	99	7	3035_DN
Drug	Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A	ADAM8 ZYX CD6 MBNL2 LRP1 TAB1 PLPPR2	2.32e-05	195	99	7	4326_DN
Drug	Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; PC3; HG-U133A	CTC1 SCYL3 ARFGEF1 ZYX HOXC10 ACAN MCAT	2.40e-05	196	99	7	1958_UP
Drug	3-nitropropionic acid; Down 200; 10uM; MCF7; HT_HG-U133A	ADAM8 HEYL MBNL2 MALL SMPD1 PAX1 RERE	2.40e-05	196	99	7	6367_DN
Drug	Dosulepin hydrochloride [897-15-4]; Up 200; 12uM; HL60; HG-U133A	NRIP1 FAM168B ADAM8 ATXN1 ACAN FAM222B PLPPR2	2.40e-05	196	99	7	1713_UP
Drug	Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	MBNL2 NBEAL2 FAM222B TAB1 RERE CDON SORL1	2.40e-05	196	99	7	7353_DN
Drug	Pinacidil [85371-64-8]; Down 200; 16.4uM; HL60; HT_HG-U133A	ARFGEF1 DAG1 ADAM8 NBEAL2 TAB1 PLPPR2 RBFOX2	2.40e-05	196	99	7	2406_DN
Drug	Dehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; PC3; HT_HG-U133A	HSPG2 AMPD3 CTC1 CCDC88C HOXC10 ACAN LRP1	2.40e-05	196	99	7	6673_DN
Drug	Canavanine sulfate monohydrate (L,+) [206996-57-8]; Down 200; 13.6uM; HL60; HT_HG-U133A	DGKG PLPPR3 ADAM8 CIC TAB1 PLPPR2 RBFOX2	2.48e-05	197	99	7	2141_DN
Drug	Althiazide [5588-16-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A	HSPG2 AMPD3 CD6 MBNL2 MALL ACAN CDON	2.48e-05	197	99	7	6829_UP
Drug	Aztreonam [78110-38-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A	DAG1 LARP1 SRCAP ADAM8 HOXC10 MALL ULK2	2.48e-05	197	99	7	2282_DN
Drug	Ticarcillin sodium [4697-14-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	IRF2BP1 TROAP SRCAP FBXO46 FAM168A ULK2 PLPPR2	2.48e-05	197	99	7	7185_DN
Drug	Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; HL60; HT_HG-U133A	AMPD3 CTC1 CD6 FAM168A MBNL2 ULK2 PLPPR2	2.48e-05	197	99	7	2532_DN
Drug	(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; PC3; HT_HG-U133A	HSPG2 DAG1 CD6 FAM168A LRP1 SMPD1 ULK2	2.48e-05	197	99	7	6663_DN
Drug	Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A	SRCAP ZYX CIC MBNL2 SMPD1 GARRE1 GAB1	2.56e-05	198	99	7	3292_DN
Drug	CGX 0596987; Down 200; 20uM; MCF7; HT_HG-U133A	SRCAP HEYL MBNL2 MALL PAX1 GAB1 CDON	2.65e-05	199	99	7	6364_DN
Drug	Sparteine (-) [90-39-1]; Down 200; 17uM; HL60; HT_HG-U133A	DGKG SRCAP LILRB1 CIC TAB1 PLPPR2 RBFOX2	2.73e-05	200	99	7	2134_DN
Drug	G11459	DAG1 CDH23 CD6 RERE	3.64e-05	43	99	4	CID000472328
Drug	prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A	AMPD3 LAMA3 ATXN1 MBNL2 MALL CDON	9.08e-05	167	99	6	5212_UP
Drug	methylmagnesium bromide	IKZF4 CD6	1.12e-04	4	99	2	CID000006349
Drug	Thioridazine hydrochloride [130-61-0]; Up 200; 9.8uM; MCF7; HT_HG-U133A	TBX3 SRCAP CD6 ATXN1 MALL CDON	1.25e-04	177	99	6	4164_UP
Drug	prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A	SRCAP PER2 MALL SMPD1 TAB1 GAB1	1.69e-04	187	99	6	6975_UP
Drug	17-AAG; Up 200; 1uM; PC3; HT_HG-U133A	TCF4 CIC LDB3 PER2 GAB1 CDON	1.79e-04	189	99	6	4450_UP
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A	HSPG2 IRF2BP1 CD6 LLGL1 LRP1 SMPD1	1.84e-04	190	99	6	4274_UP
Drug	Denatonium benzoate [3734-33-6]; Down 200; 9uM; HL60; HT_HG-U133A	TCF4 NRCAM SEC31B SMPD1 TAB1 RERE	1.89e-04	191	99	6	3123_DN
Drug	Syrosingopine [84-36-6]; Up 200; 6uM; MCF7; HT_HG-U133A	CTC1 SRCAP CD6 MBNL2 GARRE1 GAB1	1.95e-04	192	99	6	6213_UP
Drug	Isoetharine mesylate salt [7279-75-6]; Up 200; 12uM; PC3; HT_HG-U133A	TCF4 IRF2BP1 CTC1 HOXC10 NBEAL2 CDON	1.95e-04	192	99	6	5812_UP
Drug	Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; PC3; HT_HG-U133A	HSPG2 IRF2BP1 GATA4 LDB3 CD6 LRP1	1.95e-04	192	99	6	4268_UP
Drug	Flunisolide [3385-03-3]; Up 200; 9.2uM; PC3; HT_HG-U133A	HSPG2 IRF2BP1 ADAM8 ACAN LRP1 GAB1	1.95e-04	192	99	6	4303_UP
Drug	Resveratrol [501-36-0]; Up 200; 17.6uM; HL60; HG-U133A	NRIP1 FAM168B SEC31B LILRB1 SMPD1 RBFOX2	2.00e-04	193	99	6	1715_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	NRIP1 LAMA3 ESRP2 CCDC88C HOXC10 TAB1	2.00e-04	193	99	6	5215_DN
Drug	Oleandomycin phosphate [7060-74-4]; Up 200; 5uM; PC3; HG-U133A	HSPG2 IRF2BP1 CTC1 ACAN RBM47 PLPPR2	2.06e-04	194	99	6	1935_UP
Drug	Mefexamide hydrochloride [3413-64-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A	AMPD3 DAG1 SRCAP HOXC10 MALL RERE	2.06e-04	194	99	6	2284_DN
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A	HSPG2 IRF2BP1 ZYX CD6 TAB1 RERE	2.06e-04	194	99	6	4242_DN
Drug	Hydralazine hydrochloride [304-20-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A	TCF4 AMPD3 RAPGEF1 SRCAP ADAM8 CD6	2.12e-04	195	99	6	4746_UP
Drug	Piromidic acid [19562-30-2]; Up 200; 13.8uM; MCF7; HT_HG-U133A	TBX3 DGKG MBNL2 ACAN GAB1 CDON	2.12e-04	195	99	6	3335_UP
Drug	Khellin [82-02-0]; Down 200; 15.4uM; HL60; HG-U133A	TCF4 ESS2 DAG1 PLPPR3 FBXO46 FAM222B	2.12e-04	195	99	6	2004_DN
Drug	Fusidic acid sodium salt [751-94-0]; Down 200; 7.4uM; HL60; HT_HG-U133A	HSPG2 CIC ATXN1 NBEAL2 FAM222B PLPPR2	2.12e-04	195	99	6	1293_DN
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; PC3; HT_HG-U133A	DGKG CD6 ATXN1 LRP1 RERE CDON	2.12e-04	195	99	6	4467_UP
Drug	Minaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; HL60; HG-U133A	NRIP1 IRF2BP1 ARFGEF1 FBXO46 ACAN FAM222B	2.12e-04	195	99	6	1968_DN
Drug	Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; HL60; HT_HG-U133A	CTC1 GATA4 SRCAP ADAM8 HOXC10 ACAN	2.12e-04	195	99	6	3124_UP
Drug	2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A	IRF2BP1 NRCAM SRCAP CIC HOXC10 NBEAL2	2.12e-04	195	99	6	1665_DN
Drug	Estropipate [7280-37-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A	AMPD3 CIC FAM168A MALL ACAN SMPD1	2.12e-04	195	99	6	6808_UP
Drug	Methacycline hydrochloride [3963-95-9]; Down 200; 8.4uM; HL60; HT_HG-U133A	HSPG2 SEC31B MBNL2 SMPD1 PLPPR2 RBFOX2	2.12e-04	195	99	6	2901_DN
Drug	Spaglumic acid [4910-46-7]; Down 200; 13.2uM; HL60; HT_HG-U133A	SRCAP ADAM8 CIC ATXN1 NBEAL2 TAB1	2.12e-04	195	99	6	2962_DN
Drug	cm y	SLC7A6 PER2 RBFOX2	2.16e-04	27	99	3	CID016058609
Drug	Benperidol [2062-84-2]; Down 200; 10.4uM; PC3; HT_HG-U133A	ZYX HOXC10 CD6 MBNL2 NBEAL2 GAB1	2.17e-04	196	99	6	4196_DN
Drug	D-cycloserine [68-41-7]; Up 200; 39.2uM; MCF7; HT_HG-U133A	HSPG2 AMPD3 ADAM8 CIC CD6 GAB1	2.17e-04	196	99	6	6782_UP
Drug	Oxybenzone [131-57-7]; Down 200; 17.6uM; PC3; HT_HG-U133A	TCF4 SRCAP ADAM8 FBXO46 ZYX SMPD1	2.17e-04	196	99	6	6309_DN
Drug	Sulfaguanidine [57-67-0]; Down 200; 18.6uM; HL60; HG-U133A	FAM168B ESS2 SCYL3 PHF2 SEC24C ACAN	2.17e-04	196	99	6	1995_DN
Drug	Ornidazole [16773-42-5]; Up 200; 18.2uM; MCF7; HT_HG-U133A	DGKG SRCAP ADAM8 ZYX LLGL1 GAB1	2.23e-04	197	99	6	5483_UP
Drug	Ursolic acid [77-52-1]; Down 200; 8.8uM; PC3; HT_HG-U133A	AMPD3 ESS2 HOXC10 ATXN1 SMPD1 RBFOX2	2.23e-04	197	99	6	2067_DN
Drug	Nisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; HL60; HT_HG-U133A	NRCAM ZNF185 HEYL LDB3 CD6 CDON	2.23e-04	197	99	6	3117_UP
Drug	Tubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; MCF7; HT_HG-U133A	HSPG2 AMPD3 HOXC10 ULK2 PLPPR2 SORL1	2.23e-04	197	99	6	2887_DN
Drug	Clofilium tosylate [92953-10-1]; Up 200; 7.8uM; MCF7; HT_HG-U133A	HSPG2 CIC PER2 MALL ACAN CDON	2.23e-04	197	99	6	6830_UP
Drug	Ginkgolide A [15291-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A	HSPG2 LDB3 MALL ACAN GAB1 CDON	2.23e-04	197	99	6	4121_UP
Drug	Harmane hydrochloride [21655-84-5]; Down 200; 18.2uM; HL60; HT_HG-U133A	TCF4 DGKG SRCAP ADAM8 GAB1 RBFOX2	2.23e-04	197	99	6	2150_DN
Drug	Orlistat; Up 200; 10uM; MCF7; HT_HG-U133A	AMPD3 SRCAP CD6 PER2 RERE GAB1	2.23e-04	197	99	6	6383_UP
Drug	Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; PC3; HT_HG-U133A	TCF4 CD6 ACAN LRP1 TAB1 RERE	2.23e-04	197	99	6	6629_DN
Drug	fludrocortisone acetate; Up 200; 1uM; MCF7; HG-U133A	MYCBP2 LAMA3 CD6 LLGL1 MBNL2 NBEAL2	2.23e-04	197	99	6	281_UP
Drug	Pirenzepine dihydrochloride [29868-97-1]; Up 200; 9.4uM; HL60; HG-U133A	SCYL3 LLGL1 ACAN NBEAL2 PAX1 IGSF9B	2.23e-04	197	99	6	1388_UP
Drug	Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; MCF7; HT_HG-U133A	HSPG2 IRF2BP1 IKZF4 PER2 MALL RERE	2.23e-04	197	99	6	5250_UP
Drug	valdecoxib; Up 200; 10uM; PC3; HT_HG-U133A	NRCAM SRCAP IKZF4 ACAN PAX1 GAB1	2.23e-04	197	99	6	6378_UP
Drug	Minaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	NRCAM SRCAP ZYX CIC SMPD1 PLPPR2	2.23e-04	197	99	6	1468_DN
Drug	Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; HL60; HT_HG-U133A	IRF2BP1 NRCAM LAMA3 CD6 LRP1 SMPD1	2.30e-04	198	99	6	3033_UP
Drug	Aceclofenac [89796-99-6]; Down 200; 11.2uM; MCF7; HT_HG-U133A	IRF2BP1 GATA4 LAMA3 SRCAP ZYX CD6	2.30e-04	198	99	6	2281_DN
Drug	Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; PC3; HG-U133A	HSPG2 IRF2BP1 SCYL3 LLGL1 SEC24C ACAN	2.30e-04	198	99	6	1917_UP
Drug	Morantel tartrate [26155-31-7]; Up 200; 10.8uM; PC3; HT_HG-U133A	CTC1 ZYX CCDC88C ACAN LRP1 CDON	2.30e-04	198	99	6	1798_UP
Drug	Pirenzepine dihydrochloride [29868-97-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A	TCF4 AMPD3 ADAM8 HEYL CD6 MALL	2.30e-04	198	99	6	2234_UP
Drug	Erythromycin [114-07-8]; Up 200; 5.4uM; PC3; HG-U133A	TCF4 IRF2BP1 CTC1 DAG1 HOXC10 RBM47	2.30e-04	198	99	6	1928_UP
Drug	Loracarbef [121961-22-6]; Down 200; 10.8uM; MCF7; HT_HG-U133A	IRF2BP1 LAMA3 CIC HOXC10 ULK2 PLPPR2	2.30e-04	198	99	6	5492_DN
Drug	Sulfathiazole [72-14-0]; Up 200; 15.6uM; HL60; HG-U133A	TCF4 SRCAP CCDC88C NBEAL2 GARRE1 RBFOX2	2.30e-04	198	99	6	1963_UP
Drug	Tropine [120-29-6]; Down 200; 28.4uM; MCF7; HT_HG-U133A	FBXO46 ZYX CCDC88C FAM168A FAM222B RERE	2.30e-04	198	99	6	6264_DN
Drug	Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; HL60; HT_HG-U133A	NRCAM ZNF185 ESRP2 CD6 LLGL1 ACAN	2.30e-04	198	99	6	2549_UP
Drug	Naloxone hydrochloride [357-08-4]; Up 200; 11uM; PC3; HG-U133A	HSPG2 ARFGEF1 ADAM8 PHF2 ACAN PLPPR2	2.30e-04	198	99	6	1924_UP
Drug	Molsidomine [25717-80-0]; Down 200; 16.6uM; MCF7; HT_HG-U133A	HSPG2 IRF2BP1 SRCAP MBNL2 ULK2 PLPPR2	2.36e-04	199	99	6	2862_DN
Drug	Iobenguane sulfate; Up 200; 10.8uM; HL60; HG-U133A	FAM168B ESS2 SCYL3 SEC31B CD6 ACAN	2.36e-04	199	99	6	1729_UP
Drug	Methyldopate hydrochloride [2508-79-4]; Down 200; 14.6uM; PC3; HT_HG-U133A	AMPD3 CD6 MBNL2 ACAN PLPPR2 GAB1	2.36e-04	199	99	6	6640_DN
Drug	genistein; Down 200; 1uM; MCF7; HG-U133A	SRCAP MALL ACAN ZFR2 LRP1 GAB1	2.36e-04	199	99	6	267_DN
Drug	Thiorphan [76721-89-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A	LAMA3 ARFGEF1 ZYX TXLNA FAM168A ULK2	2.36e-04	199	99	6	6249_DN
Drug	Mefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; HL60; HG-U133A	IRF2BP1 LARP1 SLC7A6 TXLNA ACAN RERE	2.36e-04	199	99	6	1364_DN
Drug	Phenethicillin potassium salt [132-93-4]; Up 200; 10uM; MCF7; HT_HG-U133A	DGKG SRCAP CD6 ACAN PLPPR2 CDON	2.36e-04	199	99	6	6105_UP
Drug	Gleevec; Down 200; 10uM; MCF7; HG-U133A	IKZF4 CD6 LLGL1 MBNL2 IGSF9B GAB1	2.36e-04	199	99	6	366_DN
Drug	Oxantel pamoate [68813-55-8]; Down 200; 6.6uM; HL60; HT_HG-U133A	TCF4 SLC7A6 SEC31B ATXN1 NBEAL2 FAM222B	2.36e-04	199	99	6	1277_DN
Drug	Lidoflazine [3416-26-0]; Down 200; 8.2uM; MCF7; HT_HG-U133A	NRCAM ZYX PHF2 FAM168A ULK2 GARRE1	2.42e-04	200	99	6	6278_DN
Drug	Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A	SRCAP ADAM8 ACAN SMPD1 TAB1 RERE	2.42e-04	200	99	6	3896_DN
Drug	Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; PC3; HG-U133A	NRIP1 TCF4 TBX3 PDHX PER2 RBFOX2	2.42e-04	200	99	6	1952_DN
Disease	Malignant neoplasm of breast	NRIP1 TBX3 NRCAM DGKG SIX4 MAGEE1 DLL1 SHROOM2 CIC HEYL LLGL1 PER2 GAB1 SORL1	7.62e-06	1074	94	14	C0006142
Disease	myotonic dystrophy type 1 (is_marker_for)	LDB3 RBFOX2	1.00e-05	2	94	2	DOID:11722 (is_marker_for)
Disease	FEV/FEC ratio	HSPG2 AMPD3 MRPS35 CDH23 DGKG PDHX IKZF4 PHF2 DST ACAN LRP1 PLPPR2 CDON SORL1	3.38e-05	1228	94	14	EFO_0004713
Disease	migraine disorder, type 1 diabetes mellitus	RERE SLC45A1	9.98e-05	5	94	2	MONDO_0005147, MONDO_0005277
Disease	white matter volume measurement	SGIP1 CIC CDON	1.45e-04	32	94	3	EFO_0008320
Disease	myotonic dystrophy type 1 (implicated_via_orthology)	SIX4 MBNL2	1.49e-04	6	94	2	DOID:11722 (implicated_via_orthology)
Disease	Spinocerebellar Ataxia Type 2	CIC CCDC88C ATXN1	1.74e-04	34	94	3	C0752121
Disease	Spinocerebellar Ataxia Type 1	CIC CCDC88C ATXN1	1.74e-04	34	94	3	C0752120
Disease	Spinocerebellar Ataxia Type 5	CIC CCDC88C ATXN1	1.74e-04	34	94	3	C0752123
Disease	Spinocerebellar Ataxia Type 7	CIC CCDC88C ATXN1	1.74e-04	34	94	3	C0752125
Disease	Spinocerebellar Ataxia Type 6 (disorder)	CIC CCDC88C ATXN1	1.74e-04	34	94	3	C0752124
Disease	Ataxia, Spinocerebellar	CIC CCDC88C ATXN1	1.74e-04	34	94	3	C0087012
Disease	Spinocerebellar Ataxia Type 4	CIC CCDC88C ATXN1	1.90e-04	35	94	3	C0752122
Disease	myeloid white cell count	NRIP1 TCF4 AMPD3 CDH23 DGKG KMT2E CIC CELA3B ATXN1 RERE SORL1	1.95e-04	937	94	11	EFO_0007988
Disease	remission	HSPG2 CELA3B	2.09e-04	7	94	2	EFO_0009785
Disease	breast cancer, ovarian carcinoma	NRIP1 ARHGEF5 CCDC88C	2.25e-04	37	94	3	EFO_0001075, MONDO_0007254
Disease	Neurodevelopmental Disorders	TCF4 SRCAP KMT2E PHF2	2.27e-04	93	94	4	C1535926
Disease	MENTAL RETARDATION, AUTOSOMAL DOMINANT 40	KMT2E DLL1	3.56e-04	9	94	2	C4225275
Disease	open-angle glaucoma	DGKG DST PKHD1 RERE MOV10	3.71e-04	191	94	5	EFO_0004190
Disease	smoking status measurement, forced expiratory volume	DGKG PKHD1	5.42e-04	11	94	2	EFO_0004314, EFO_0006527
Disease	blood urea nitrogen measurement	SYNPO2 PLPPR3 USP38 PKHD1 RBM47 GAB1 SORL1	6.15e-04	452	94	7	EFO_0004741
Disease	congenital diaphragmatic hernia (implicated_via_orthology)	GATA4 LRP1	6.49e-04	12	94	2	DOID:3827 (implicated_via_orthology)
Disease	irritable bowel syndrome	TCF4 PHF2 PER2 RERE	8.31e-04	131	94	4	EFO_0000555
Disease	schizophrenia, intelligence, self reported educational attainment	TCF4 KMT2E SHANK3 ATXN1 IGSF9B RERE	8.52e-04	346	94	6	EFO_0004337, EFO_0004784, MONDO_0005090
Disease	bitter alcoholic beverage consumption measurement	TCF4 CIC IGSF9B SORL1	8.79e-04	133	94	4	EFO_0010092
Disease	Pneumoconiosis	CDH23 ACAN	8.91e-04	14	94	2	C0032273
Disease	Bagassosis	CDH23 ACAN	8.91e-04	14	94	2	C0004681
Disease	unipolar depression, mood disorder	TCF4 DAG1 PHF2 RERE	9.04e-04	134	94	4	EFO_0003761, EFO_0004247
Disease	forced expiratory volume	AMPD3 LARP1 IKZF4 DST DMRT2 SEC24C ACAN GAB1 CDON	9.37e-04	789	94	9	EFO_0004314
Disease	Alobar Holoprosencephaly	DLL1 CDON	1.03e-03	15	94	2	C0431363
Disease	sleep duration	TCF4 MYCBP2 CTC1 CDH23 DMRT2 TAB1	1.08e-03	362	94	6	EFO_0005271
Disease	Lobar Holoprosencephaly	DLL1 CDON	1.17e-03	16	94	2	C0431362
Disease	DiGeorge Syndrome	ESS2 SEC24C	1.17e-03	16	94	2	C0012236
Disease	Semilobar Holoprosencephaly	DLL1 CDON	1.17e-03	16	94	2	C0751617
Disease	central nervous system disease (implicated_via_orthology)	IRF2BP1 SEC31B	1.17e-03	16	94	2	DOID:331 (implicated_via_orthology)
Disease	CONOTRUNCAL ANOMALY FACE SYNDROME	ESS2 SEC24C	1.17e-03	16	94	2	C0795907
Disease	Shprintzen syndrome	ESS2 SEC24C	1.17e-03	16	94	2	C0220704
Disease	visfatin measurement	LILRB1 TAB1	1.32e-03	17	94	2	EFO_0801230
Disease	retinal vasculature measurement	HSPG2 TCF4 AMPD3 CTC1 TTYH2 FBXO46 CELA3B	1.34e-03	517	94	7	EFO_0010554
Disease	breast carcinoma	NRIP1 TBX3 NELFA ARHGEF5 KHDC4 CCDC88C DLGAP3 ATXN1 SLC45A1 GAB1	1.52e-03	1019	94	10	EFO_0000305
Disease	apolipoprotein A 1 measurement	AMPD3 IRF2BP1 GATA4 DGKG HEYL LDB3 FAM168A LRP1 SORL1	1.54e-03	848	94	9	EFO_0004614
Disease	Paroxysmal atrial fibrillation	HSPG2 GATA4 ATXN1 SORL1	1.58e-03	156	94	4	C0235480
Disease	familial atrial fibrillation	HSPG2 GATA4 ATXN1 SORL1	1.58e-03	156	94	4	C3468561
Disease	Persistent atrial fibrillation	HSPG2 GATA4 ATXN1 SORL1	1.58e-03	156	94	4	C2585653
Disease	bipolar disorder, body mass index	CDH23 DGKG PKHD1	1.59e-03	72	94	3	EFO_0004340, MONDO_0004985
Disease	Antihypertensive use measurement	HSPG2 TCF4 USP38 MBNL2 RBM47	1.61e-03	265	94	5	EFO_0009927
Disease	cerebral microbleeds	HSPG2 CELA3B	1.66e-03	19	94	2	EFO_0010059
Disease	Atrial Fibrillation	HSPG2 GATA4 ATXN1 SORL1	1.74e-03	160	94	4	C0004238
Disease	diet measurement	GATA4 DGKG KHDC4 PHF2 DST ATXN1 PKHD1 IGSF9B RERE SORL1	1.88e-03	1049	94	10	EFO_0008111
Disease	Diuretic use measurement	NRIP1 GATA4 USP38 MOV10	2.12e-03	169	94	4	EFO_0009928
Disease	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	GATA4 NUP155	2.23e-03	22	94	2	C1843687
Disease	functional brain measurement	HSPG2 CELA3B MBNL2	2.31e-03	82	94	3	EFO_0007849
Disease	depressive symptom measurement	TCF4 SGIP1 DAG1 PHF2 PKHD1 RERE	2.45e-03	426	94	6	EFO_0007006
Disease	Autism Spectrum Disorders	SHANK3 CIC USH2A	2.56e-03	85	94	3	C1510586
Disease	congenital heart disease (is_implicated_in)	GATA4 RBFOX2	2.65e-03	24	94	2	DOID:1682 (is_implicated_in)
Disease	household income	TCF4 SGIP1 KMT2E IKZF4 ATXN1	2.92e-03	304	94	5	EFO_0009695
Disease	insomnia measurement	TCF4 MYCBP2 PHF2 PER2 FAM222B SORL1	2.97e-03	443	94	6	EFO_0007876

Protein segments in the cluster

Peptide	Gene	Start	Entry
IPPLTAPVTPDSGYS	CTDSPL2	226	Q05D32
GPVTPIPVLYPESAS	CTC1	196	Q2NKJ3
PVPVYPAVGNHESTP	SMPD1	311	P17405
PGTPISVAYTPSLPD	ARFGEF1	376	Q9Y6D6
YPITPASVSARPPVA	ARHGEF5	526	Q12774
VSSPPFPVPVYTRQA	ADAM8	756	P78325
TLPAAYATPQPGTPV	ATXN1	101	P54253
PYSVRIPENTPVGTP	CDH23	136	Q9H251
PVVTGATSLPTPAPY	AMPD3	111	Q01432
PPFQGRPITPVYTVA	RBM47	511	A0AV96
GPSYTPVPGSTRPIR	HSPG2	2141	P98160
VRAVPPTAIPAYPGV	RBFOX2	296	O43251
FPTLQPTVATTPYGP	LLGL1	271	Q15334
PAGSNSYQPVPITIP	CD6	446	P30203
PPPNRYGVSSPISLA	PAPOLB	16	Q9NRJ5
SESATYVPVAPPTPA	LARP1	291	Q6PKG0
VPPTAYEGPSTSVVP	MAGEE1	176	Q9HCI5
IPSAIYPAPVAAPRT	FAM168A	176	Q92567
TGYARVPTQPHAPIP	LAMA3	2606	Q16787
YTPAGPQVPPLARGT	LDB3	521	O75112
PPATSYAPSDVPSGV	MALL	6	Q13021
VVPASSYIPSSETPP	NELFA	331	Q9H3P2
LSVVAPTPTPAPVYD	NRCAM	631	Q92823
RLTPSVTPAYTPGFP	DST	546	Q03001
VTPAYTPGFPSGLVP	DST	551	Q03001
PTPGNTYQIPRTFPE	GAB1	311	Q13480
TGTISYRSLPPAAPP	LRP1	3921	Q07954
TGYAINPSRDPPPSI	AQP7B	226	A0A075B734
VPPGLPSSVYAPSAS	TCF4	176	P15884
TIPGYVEPTAVATPP	DAG1	406	Q14118
TAPPYVGVRPCSASP	CCDC88C	1651	Q9P219
PAAYSLPVFPAPGTV	PER2	851	O15055
ALQSYPRPTTPAPVV	FBXO46	186	Q6PJ61
PLQATAGPSYPRPVI	PDHX	246	O00330
AGPSYPRPVIPPVST	PDHX	251	O00330
PPVAPYATVAPSTLA	FAM222B	131	Q8WU58
PTGISRVPTGYPSDL	FAM222B	346	Q8WU58
YSPVTPVTPGTPGNT	KMT2E	931	Q8IZD2
SYPGVVKTPVSPTFP	NRIP1	1001	P48552
AYVAVPTPNSSSPGP	HEYL	291	Q9NQ87
VTVTSGPPPSIPYAG	HMGXB4	356	Q9UGU5
PILGSPVYSSSPVPS	NUP155	596	O75694
YTPVGTSPLPGILPT	ACAN	746	P16112
PGPEAASRVPPALVY	PLPPR2	61	Q96GM1
PPFTLPSGLAVYPAV	SCYL3	16	Q8IZE3
ASYRRGASSFPVPPP	MCAT	16	Q8IVS2
PAPAARPRTPSVAYT	PAX1	431	P15863
PPVPRSSSSESPVVY	DGKG	146	P49619
GAASSPVYVPTPRVP	GATA4	31	P43694
PVYVPTPRVPSSVLG	GATA4	36	P43694
REPPPPYVTPATFET	ESS2	96	Q96DF8
AETYVGGTFPLPPPV	DMRT2	216	Q9Y5R5
VSPEPPCTYGSAVTP	DLL1	71	O00548
DYVPSLSAPQRPPGT	C19orf71	166	A6NCJ1
LPSPSAPLYAVTSPG	GARRE1	991	O15063
ASSPPVGIPKYPVVS	CDON	686	Q4KMG0
PQPGPRAPTYSVFRT	DLGAP3	716	O95886
LVAVASGYGPPSSRP	CELA3B	11	P08861
PVGRPLSSCSYPPSV	HOXC10	91	Q9NYD6
APYLAPVTPGVGLVP	MBNL2	131	Q5VZF2
LPGYTQPSAISSVPP	KHDC4	336	Q7Z7F0
PTPRSYFTVPRADPV	DVL1	341	O14640
PYGPPPTSAQVATQL	SEC24C	126	P53992
SYLAIPGSVPRPPIS	SLC45A1	421	Q9Y2W3
PPPTIVVGRHSPAYA	IKZF4	481	Q9H2S9
PYSAETPGVPSPIAA	IRF2BP1	411	Q8IU81
APHPVTVPTYRAPGT	FAM168B	171	A1KXE4
AISTYNRTGPLPPGP	PTGR1	241	Q14914
PSYTVVGRTPPARPP	ODF3L2	181	Q3SX64
VYSATPVPTPSLPER	MRPS35	26	P82673
APPEGLSPPVISYVS	USH2A	4261	O75445
SPPVPCPVGSTYRRT	SORL1	711	Q92673
SPYSIPVPVPDGSSL	TBX3	641	O15119
DAPYSPTARVGPSVP	PHF2	901	O75151
TPSPAPAAGGRVYPV	TAB1	376	Q15750
PSQEGPSPAVPSIYA	LILRB1	631	Q8NHL6
VTGTTRPAPYIIFGP	MOV10	511	Q9HCE1
TGLPTPPVPATLAYT	NBEAL2	736	Q6ZNJ1
YSPSVPVSFPGLIPS	SIX4	436	Q9UIU6
GRPFPTPSPASLDVY	SHROOM2	1091	Q13796
SVPAPYISVTPDASP	MYCBP2	3426	O75592
TPIVHQVYPPSGVPG	PKHD1	136	P08F94
PTTIAAVPPYIGPDT	RERE	1236	Q9P2R6
AVPPYIGPDTPALRT	RERE	1241	Q9P2R6
PHGVSPGPATTYRVT	SEC31B	731	Q9NQW1
LPAARVPAAPTPVAY	ESRP2	611	Q9H6T0
LTVPPGYTFPPAAAT	SRCAP	1131	Q6ZRS2
RVPSAPAPSLAYGAP	CIC	646	Q96RK0
PAPPAATPAGVYTVF	TNRC18	346	O15417
PPTLPLPTVGASYTA	ZFR2	21	Q9UPR6
PYSAVTPPPDAFSRG	SYNPO2	621	Q9UMS6
TAPIPSVPYAPFAAI	RAPGEF1	496	Q13905
PPPPGRAYDTVRSSF	SHANK3	841	Q9BYB0
SVSEPPGLPRVSAYV	SPATS1	81	Q496A3
PPFYVPEVGSPLSSV	IGSF9B	981	Q9UPX0
EGPAPPSLYPTVQAR	PLPPR3	461	Q6T4P5
PPTYRTVVSSPGPGS	SGIP1	416	Q9BQI5
NVPLIGRASPPPTYS	TTYH2	496	Q9BSA4
LEVPSPTRYQVPSPS	STPG3	101	Q8N7X2
RVPSPGPPTLTSYSV	TROAP	331	Q12815
PGPSEEPVVYNPTTA	USP38	651	Q8NB14
PGRPTPTYHLVPNTS	SLC7A6	6	Q92536
SSRPYSPSPLVGTIP	ULK2	471	Q8IYT8
ARVSSGYVPPPVATP	ZYX	166	Q15942
PPSTRAPTGYIIRGV	ZNF185	76	O15231
IYPTPKVVAGTPQSP	SLC36A4	476	Q6YBV0
PRVTEAPCYPGAPST	TXLNA	516	P40222